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Abstract 
 
Two families of amine-functionalised silicone polymers were prepared using 
monomeric (3-aminopropyl)triethoxysilane (APTES) and (3-
trimethoxysilylpropyl)diethylene triamine (TMSPDT). Schiff base derivatives of these 
polymers were synthesised using salicylaldehyde. The same suite of polymers were 
also formed as a surface coating on magnetite nanoparticles (Fe3O4-MNPs). 
Copper(II) ions were coordinated to the pendant amine groups of all of the polymers. 
In vitro tests using the fungal pathogen, Candida albicans, revealed that the silicone 
polymers, their Cu(II) complexes and the Schiff base salicylate derivatives inhibited 
cell growth. None of the silicone-coated Fe3O4-MNPs were bioactive. 
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1.1 Project Aims 
 
 
The central aims of this project were (i) to synthesise and characterise water-
insoluble, functionalised silicone polymers and silicone-coated magnetic 
nanoparticles (MNPs), with each having bioactive copper(II) ions anchored to their 
outer surface and, (ii) to assess the ability of these metal-complexed polymeric 
materials to inhibit the growth of a fungal pathogen through the slow, sustained 
release of the bio-destructive copper(II) ion. It is envisaged that such polymeric 
materials could be added to a medium containing actively growing microbial cells, 
perform their fungistatic/fungicidal duty, be recovered (by filtration or using a 
magnet) from the medium and be recycled. Such materials could find utility in drug 
delivery, personal care compositions, surface cleaners, swimming pool water 
disinfection systems, etc. Additionally, the bioactive polymers could be blended into 
paints and other solid surface polymer materials to provide a dynamic barrier to 
microbial growth. 
 
Introduction 
 
This Introduction section is configured to give the reader a general overview of 
functionalised silicone polymers, nanoparticles and the problems associated with 
microbial pathogens. Particular attention is given to the fungal species, Candida 
albicans, as this was the test organism used in the current study. The antimicrobial 
activity of the copper(II) ion is reviewed as this was the metal ion employed in the 
present work. 
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1.2 Polysiloxanes 
 
 
1.2.1 Polysiloxanes 
 
Polysiloxanes are inorganic polymers which contain a repeating backbone unit of 
O-Si-O bonds. In the medicinal context, polysiloxanes have been successfully 
utilised in short-term and long-term in-dwelling catheters, drains, shunts and 
contact lenses1. Two examples of these polymers that are used in a medicinal 
context are shown in Figure 1. 
 
  
(a) (b) 
Figure 1. Examples of polysiloxanes used for medicinal purposes: (a) irrigation 
catheter2 and (b) silicone gel-sheet for scar/burn treatment3.   
 
The siloxane linkage (Si-O-Si) in the backbone is characteristic of most silicone 
polymers. Whilst polysilanes have Si-Si bonds and polycarbosilanes contain Si-C 
linkages, neither have the siloxane linkage4. 
 
Although silicon is immediately below carbon in Group 14 of the Periodic Table, the 
elements exhibit very different chemical properties. Carbon and silicon both have a 
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normal oxidation state of 4, but silicon can expand its valence shell by using low-lying 
3d orbitals for bonding5. Silanes are less stable than their alkane counterparts due to 
the fact that the Si-Si bond energy is considerably weaker (ca. 170 kJ mol-1) than that 
of the C-C bond5. However, Si-O bonds are noticeably stronger (ca. 88 kJ mol-1) than 
C-O bonds. The Si-O bond distance (1.64 Å) is shorter than the sum of the covalent 
radii (1.76 Å), implying a partial double bond character in the Si-O bond6. The double 
bond character is also due to the partial overlap of the empty, low energy Si 3d 
orbitals with the populated p orbitals of oxygen. The large electronegativity 
differences between silicon and oxygen atoms (1.8 and 3.5, respectively) causes 
partial ionic character6. The large bond angles (140-180°) in the Si-O-Si backbone 
allows for a high degree of flexibility, in contrast to the tighter angles in vinyl 
polymers and polyethers5. It is this flexibility of the polysiloxanes which imparts the 
characteristic low glass-transition temperature, melting temperatures and liquid 
crystalline behaviours6. The high thermal stability of the polysiloxanes is due to the 
inherent strength of the Si-O bond and the flexibility of the O-Si-O segments of the 
whole polymer. 
 
The silicon atom in a polyorganosiloxane can be bonded to one, two or three organic 
groups, with oxygen in the remaining valencies. M, D, T and Q shorthand notations 
are used to indicate mono-, di-, tri- and quaternary-functionality, respectively7  
(Table 1). Depending on monomer composition, polysiloxanes can have linear, 
branched or cross-linked structures.   
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Table 1. Polyorganosilane structural units. 
 
 
Structural composition 
 
 
Formula 
 
Functionality 
 
Symbol 
 
 
 
R3SiO1/2 
 
Monofunctional 
 
M 
 
 
 
 
R2SiO2/2 
 
Difunctional 
 
D 
 
 
 
RSiO3/2 
 
Trifunctional 
 
T 
 
 
 
SiO4/2 
 
Quatrafunctional 
 
Q 
 
 
Silicone polymers, having specific physical properties, can be produced by varying the 
nature of the R substituent, e.g. vinyl, trifluoropropyl, alkyl amines. Such silicones are 
used as fluids, emulsions, resins and elastomers8. Silicones are renowned for their 
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biocompatibility and biodurability, and both of these features have been attributed 
to the inherent chemical and thermal stability of the polymers, their low surface 
tension and hydrophobicity1. Polysiloxanes have been shown to be suitable hosts for 
holding metal nanoparticles and also metal ions9 and this has been attributed to the 
unusual freedom of rotation around the Si-O bond which allows the polymers a high 
degree of flexibility while maintaining their integrity. 
 
The use of polysiloxanes in breast implants was linked to rheumatoid arthritis and 
other diffuse connective tissue diseases in the 1980s. However, there has been no 
clear scientific evidence to substantiate the claims10. Implants manufactured by the 
French company, Poly Implant Prothese (PIP), were banned for use in 2010 due to 
concerns about their safety. It was found that the manufacturers used inferior grade  
polydimethylsiloxane which did not reach the high standards required for use in 
medical products11.  
 
 
1.2.2 Synthesis of Silicone Polymers 
 
 
The polymerisation of alkoxysiloxanes (Figure 2) involves a bimolecular 
nucleophilic substitution reaction (SN2) in which the alkoxy groups are hydrolysed 
to give silanols (Si-OH)12. Concomitant loss of a water molecule from two silanols 
leads to the formation of siloxanes (Si-O-Si) in a condensation-dehydration 
reaction. 
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Figure 2. General scheme for the polymerization of a trialkoxysilane (hydrolysis 
followed by condensation).  
 
The rates of the hydrolysis and condensation reactions are influenced by the organic 
substituent (R´) on the siloxane monomer, the nature of the alkoxy group, pH, the 
presence of a catalyst, silane concentration, temperature, inductive effects and steric 
effects6 (see equations 1-3 below).        
 
RSiZ3 + 3H2O    RSi(OH)3 + 3HZ hydrolysis  (1) 
3RSi(OH)3    3RSiO3/2 + 4.5H2O condensation  (2) 
RSi(OH)3 + RSiZ3               2RSiO3/2 + 3HZ  condensation  (3) 
(Z = OR´, Cl, OAc etc.) 
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Reaction mechanisms for the acid-catalysed and base-catalysed hydrolysis reactions 
are shown in Figure 3. 
 
 
Figure 3. Reaction mechanisms for (a) the acid-catalysed and (b) the base-catalysed 
hydrolysis reactions of silanes. 
 
The alkoxy groups on the silane monomer influence the rate of hydrolysis. Hydrolysis 
occurs faster with better leaving groups such as the alkoxy groups (as alcohols). 
Lower pKa values give better leaving groups and leaving group ability is determined 
by the pKa value of the conjugate acid (e.g. methanol, ethanol or hydrochloric acid)13. 
The chloride ion is an excellent leaving group because hydrochloric acid, the 
conjugate acid, has a pKa value of -7. When a chloride ion is liberated as a leaving 
group during the hydrolysis reaction, the hydrochloric acid formed catalyses the 
subsequent condensation reaction14.  
 
(a) 
(b) 
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The pKa value for methanol is 15.2 whilst ethanol has a pKa value of 15.9. Methanol 
and ethanol are the conjugate acids for methoxy and ethoxy groups. Studies on 
methoxy and ethoxy silanes have shown that methoxy groups undergo hydrolysis 
more readily than their ethoxy homologues15,16. For the monomeric (3-
aminopropyl)triethoxysilane (mAPTES) and the monomeric  3-
trimethoxysilylpropyl)diethylenetriamine (mTMSPDT), the rate of hydrolysis is faster 
for the longer triamine monomer due to the methoxy groups, however, the rate of 
the condensation reaction is slower due to the steric hindrance of the bulky triamine 
chain16. 
 
Cross-linking of the siloxane monomers and chains affords polymeric structures 
which have enhanced thermal stability, mechanical properties and solvent 
resistance17. Cross-linking can be accomplished either by direct reaction of the 
monomers or by promoting covalent cross-linking of preformed polymer chains6. 
Curing can be stimulated using catalysts such as organic bases, carboxylic acids and 
complexes containing certain p-block and transition metal ions18. Extended curing, 
which ensures a high degree of polymer cross-linking, can be achieved by either 
raising the reaction temperature or through gamma and electron beam 
irradiation19,20.  
 
A silsesquioxane is a polymeric silicon structure of the form, RˊSiO3/2, and has an 
organic substituent, Rˊ, as an integral component of the network. Rˊ can be an alkyl 
or aryl group, with or without saturation, and it can contain functionality, such as 
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amine or epoxy. A range of silsesquioxane structures are known, such as random 
structures, oligomeric cage silsesquioxanes with 8-16 silicon atoms, partial cage 
structures, ordered ladder structures and three dimensional network structures 
(Figure 4)21. 
 
 
     (a)                                                              (b) 
Figure 4. Structures of (a) a cubic silsesquioxane oligomer, and (b) a ladder-type 
polymer structure. 
 
 
1.3 Siloxane Monomers Used in the Present Work 
 
 
1.3.1 (3-Aminopropyl)triethoxysilane (APTES) 
 
The commercially available (3-aminopropyl)triethoxysilane liquid monomer 
(mAPTES) comprises a central silicon atom, from which there is attached a propyl 
chain with a terminal amine group and three ethoxy groups (Figure 5). 
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Figure 5. Structure of monomeric APTES (mAPTES). 
 
Conversion of mAPTES to polymeric APTES (pAPTES) occurs by the two-step process 
of hydrolysis followed by condensation. mAPTES can be polymerised using water and 
hydrochloric acid22. pAPTES is a highly cross-linked silsesquioxane23, rendering it a 
stiff material with good thermal resistance22.   
 
 
1.3.2 (3-Trimethoxysilylpropyl)diethylene triamine (TMSPDT) 
 
 
Monomeric (3-trimethoxysilylpropyl)diethylene triamine (mTMSPDT) has a central 
silicon atom to which is attached a diethylenetriamine side group and three methoxy 
groups (Figure 6). mTMSPDT is liquid at room temperature and is commercially 
available. 
 
 
Figure 6. Structure of monomeric TMSPDT (mTMSPDT). 
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Like the polymerisation of mAPTES, the polymerisation of TMSPDT, to form 
pTMSPDT, occurs in consecutive hydrolysis and condensation steps. mTMSPDT can 
be polymerised in water or in an alcohol/water solvent mixture using either acid 
catalysts, such as acetic acid or hydrochloric acid, or base catalysts, such as n-
dodecylamine or sodium hydroxide24-26. Copolymerisation can be achieved with 
tetraethoxysilane, tetramethoxysilane, dimethylsilanediol or vinyltrimethoxysilane 
(VTMS)27-29.   
 
When polymerised, p(TMSPDT) forms a highly cross-linked silsesquioxane structure. 
The amine functionality in pTMSPDT allows for the adsorption of heavy metals such 
as copper(II), nickel(II), cobalt(II) and the dichromate anion, CrO42-, from aqueous 
solutions26. Silica powder modified with mTMSPDT, formed using acidic conditions, 
has been used for the removal of microorganisms such as Escherichia coli, MS2 
bacteriophage virus, albumin and the protozoan parasite, Cryptosporidium parvuum, 
from water30. CO2 adsorption is another use which utilises the amine functionality of 
the material31. TMSPDT is also a silane coupling agent and is used as a surface 
modifier and adhesion promoter as it exhibits outstanding adhesion to many 
inorganic substrates such as glass, metal or fillers32. Materials containing TMSPDT 
show good thermal resistance, however, the long chain polyamines have lower 
thermal stability than the shorter chain polyamines, such as APTES31.   
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1.4 Nanotechnology 
 
1.4.1 Definition and Description  
The definition of ‘Nano’ recommended for use by the EU Commission is: ‘Nano 
consists of natural, incidental or manufactured particles, in an unbound state or as 
an aggregate  or agglomerate  with one or more  external  dimensions in  the size 
range 1-100 nm for more than 50% of their number size distribution’. The IUPAC 
glossary of terms defines ‘nanoparticle’ as ‘microscopic particle whose size is 
measured in nanometres, often restricted to so-called nano-sized particles (NSPs: < 
100 nm in aerodynamic diameter), also called ultrafine particles’33. Nanotechnology 
is ‘the understanding and control of matter at dimensions of roughly 1-100 nm, 
where unique phenomena enable novel applications’ according to the definition of 
nanotechnology by the United States (US) Nanotechnology Initiative. Although there 
seems to be no full definition per se currently agreed upon by the scientific 
communities who carry out research in the field of nanotechnology, nanostructures, 
as the name implies, are structures with at least one dimension in the nanoscale. The 
prefix ‘nano’ means one billionth of a metre (1 x 10-9 m).   
 
Due to their size, many of the properties of nanostructures such as fluorescence, 
melting point, optical properties, band gap energy and chemical reactivity are 
observed as being different from those of the bulk counterpart34 (Figure 7). Classical 
mechanics does not explain the behaviour of nanoscale structures. At the annual 
meeting of the American Physical Society in December 1959, Professor Richard 
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Feynman called for improvements to be made to the electron microscope to progress 
the field.  In his address he stated, “...atoms on a small scale behave like nothing on 
a large scale, for they satisfy the laws of quantum mechanics.” At the nanoscale, 
quantum effects are those observed due, in part, to the large surface-to-volume ratio 
of nanoparticles35,36.   
Effects observed 
 
 
        Quantum physics  Classical physics  
 
Figure 7. Dimensions in quantum and classical physics. 
 
Nanoscale structures which exist in nature include viruses, which can be <100 nm. 
The ebola virus is filamentous and up to 970 nm long with a diameter of 80 nm, whilst 
deoxyribonucleic acid (DNA) is approximately 2.5 nm in diameter (Figure 8). Proteins 
can be less than 3 nm and individual atoms are less than 1 nm in diameter35. A particle 
which measures a few nanometres may contain as many as 105 atoms or as few as a 
couple of hundred atoms37,35.   
 
Nanomaterials have a myriad of uses. They are found in items as diverse as cosmetics, 
clothes, computers, aerospace technology38 and magnetic tapes39, and also in 
recoverable catalyst systems40. 
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(a) (b) 
Figure 8. Images of nanoscale structures that exist in nature (a) colourised TEM image 
of ebola virus41, (b) cartoon image of DNA42.  
 
Magnetic microspheres, ferrofluids (Figure 9) and nanospheres are used in targeted 
drug delivery, enzyme immobilization, RNA and DNA purification43. Biodegradable 
nanoparticles are used as magnetic resonance imaging (MRI) contrast agents, drug 
carriers, and as labelling and tracking agents in biomedical systems44-46. 
 
 
Figure 9. Ferrofluid on a magnet45. 
 
Nanoparticles are colloidal systems possessing unique properties which can be 
investigated using advanced microscopy, such as atomic force microscopy (AFM), 
transmission electron microscopy (TEM) and scanning tunnelling microscopy 
(STM)35. The improvement in imaging techniques has progressed the field of 
     
 
 
~ 16 ~ 
 
nanotechnology greatly since the invention of TEM in the 1930’s, and AFM and STM 
in the early 1980’s. A nanoparticle is comprised of between a few hundred to a few 
thousand atoms incorporated in the crystal structure and the symmetry of a 
molecule differs between the surface and the interior46.  
 
In the context of the present work, Taglietti et al.47 amino-silanized a glass surface 
using monomeric (3-aminopropyl)triethoxysilane (mAPTES) and subsequently 
anchored a monolayer of silver nanparticles (AgNPs) to the pendant amine functional 
groups (Figure 10). This stable material provided a prolonged release and high local 
concentration of Ag+ ions which promoted potent anti-biofilm activity against 
Staphylococcus epidermidis RP62A. 
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Figure 10. Silanization of glass surface with mAPTES and subsequent anchoring of 
AgNPs47.  
 
 
1.4.2 Iron Oxide Magnetic Nanoparticles (Fe3O4-MNPs) 
Magnetite (Fe3O4; comprising Fe2+(Fe3+)2(O2-)4) has been known since ancient 
times48. Fe3O4 magnetic nanoparticles (Fe3O4-MNPs) have magnetic properties which 
differ from those of the bulk material. These properties are due to both their size and 
the fact that each particle has a large magnetic moment. Fe3O4-MNPs are 
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‘superparamagnetic’ as they respond to a magnetic field but do not retain residual 
magnetization35,49,50.  
 
Saturation of the surface of metal oxides occurs by the reaction of water with the 
surface metal-oxygen (M-O) bonds. Fe3O4-MNPs are insoluble in water51 and bare 
atoms of iron and oxygen on the particle surface adsorb hydroxyl ions and protons in 
solution to give a neutral particle with a hydroxyl-rich surface46,52 (Figure 11).  
 
 
 
Figure 11. Schematic of the hydroxyl-rich surface of Fe3O4-MNPs. 
 
The surface decoration of hydroxyl groups gives rise to columbic repulsion53 and can 
be used to covalently anchor silicone polymers, using suitable alkoxy-silane 
monomers, in a condensation reaction (Figure 12)47. 
 
The size of MNPs can be tailored by covering them with a number of silicone coats54. 
As the size of the particle decreases, the ratio of the surface area to the volume of 
the particle increases. 
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Figure 12. Schematic for the surface coating of Fe3O4-MNPs with monomeric (3-
aminopropyl)triethoxysilane (mAPTES) to give pAPTES-Fe3O4-MNPs.  
 
For nanoparticles, this ratio becomes significantly large causing a large portion of the 
atoms to reside on the surface compared to those in the core of the particle. For 
example, for a particle of 1 µm in diameter, ca. 0.15% of its atoms are on the surface, 
while for a 6 nm diameter particle ca. 20% of its atoms are on the surface. It is the 
large surface-to-volume ratio of the NPs which is the controlling factor for their novel 
physical, chemical and mechanical properties compared to those of the 
corresponding bulk material.  
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Nanoparticles can be synthesised either by chemical or by physical means, including 
thermal decomposition and reduction, co-precipitation, sol-gel, reverse micelle and 
emulsion solvent evaporation35,44. 
 
Nanoparticles of Fe3O4 have a large surface to volume ratio, and for the present 
research were synthesised using a published ‘bottom-up’ approach43. When base is 
added to an aqueous mixture of Fe(II) and Fe(III) ions, magnetite (Fe3O4) is formed55 
(Figure 13). For this research, FeCl2 and FeCl3 were dissolved in water and MNPs were 
co-precipitated by the addition of NH4OH to the solution. The temperature at which 
the reaction is carried out and the concentration of ions in the reaction mixture 
control the resulting nanoparticle size. Since the properties of synthesised 
nanoparticles are affected by their size, it is necessary to have a narrow size 
distribution53. The definite composition of FeCl2 and FeCl3 allows for a precise 
reactant stoichiometric ratio (2:1) which is necessary for the co-precipitation 
reaction, as it has been reported that other ratios do not yield the correct product56. 
 
 
   
(a) (b) (c) 
Figure 13. (a) Naturally occurring magnetite (Fe3O4)57, (b) synthesised magnetite 
nanoparticles(Fe3O4-MNPs)58, and (c) MNPs in a magnetic field59.   
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Oxidation of the iron(II) ion in the aqueous solution is prevented, and particle size 
reduction is achieved by using flowing nitrogen gas during the synthesis43. In 
magnetite, iron(II) and iron(III) ions are found with both tetrahedral and octahedral 
geometry60. Fe3O4 forms in an inverse cubic spinel structure (Figure 14). The oxygen 
atoms form a face-centred cubic structure (fcc) and the iron(II) and iron(III) cations 
occupy the interstitial octahedral and tetrahedral sites, respectively61. Electron 
transfer occurs between the iron(II) and iron(III) sites62.   
 
 
(a) (b) 
Figure 14. Structure of Fe3O4. (a) The inverse spinal crystal lattice structure63and (b) 
The local coordination geometries of the iron(II) and iron(III) ions64. 
 
It is possible to extract Fe3O4-MNPs from a colloidal suspension by simply placing a 
magnet beneath the container and decanting the supernatant (Figure 15). 
Figure 15. Use of a magnet to extract Fe3O4-MNPs from a colloidal suspension. 
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1.4.3 Silicone-coated Fe3O4-MNPs as Drug Delivery and Imaging 
Systems 
 
Prescribed drugs can cause problems for patients for various reasons, such as 
insufficient active drug being available at the site where it is required, or unwanted 
side effects like nausea or hair loss occurring. For example, conventional 
chemotherapy drugs may not be site specific and thus interact with both normal and 
abnormal cells65. One method which is employed to circumvent such potential 
problems is to strategically place drug molecules at a selected location by using a 
catheter to deliver the required drugs. A selective delivery system such as this allows 
for a therapeutic dose of medication to be delivered to a specific area such as the 
site of a tumour (Figure 16).  
 
Figure 16. Targeting a tumour with microspheres66. 
 
A similar system of targeted drug delivery can be achieved by coating MNPs with 
biocompatible polymers and then attaching the required drug molecule to the 
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coated MNPs. When injected into the bloodstream, bare nanoparticles can adsorb 
proteins and agglomerate, and they can be removed quickly by macrophages67. 
Surface-coating magnetic nanoparticles with silicone polymers is a method used to 
prevent damage to biological systems, since bare magnetite can cause detrimental 
health effects43. Silicone polymers are very hydrophobic, and when these polymers 
are used to coat MNPs in a monolayer they have the effect of reducing particle-
particle magnetic interactions, hence increasing the time a drug can circulate in the 
body67. 
 
Surface coating nanoclusters with layers of silicone polymer increases the size of the 
nanocluster and passivates the surface. In addition, agglomeration is reduced and 
steric stabilisation is increased34,49,53. Silicone-polymer-coated-MNPs can be further 
functionalised to carry drugs as they are non-toxic and can be introduced 
intravenously49. As a result of their magnetic functionality these drugs can be more 
effective than conventional therapies as they can be precisely placed using a 
magnetic field51,67,68. The following example illustrates both the problem and the 
solution. The blood-brain barrier (BBB) is composed of endothelial cells with tight cell 
junctions69. It protects the central nervous system in higher mammals by preventing 
passive diffusion within the system. This protective barrier can prevent the delivery 
of a therapeutic dose of drugs to sites within the brain. In the case of brain tumours, 
such as malignant glioma, surgery often is not possible due to the risk of damaging 
healthy brain tissue. MNPs which have been functionalised with appropriate drugs 
can be delivered to the site of a brain tumour. This can be achieved by using 
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ultrasound to separate the tight junctions of the BBB. Applying a magnetic field at 
the tumour site allows the drug molecules to be delivered to the specific target 
location70-72.  
 
Xie et al. reviewed the potential use of surface-engineered magnetic nanoparticle 
assemblies for use in cancer imaging and therapy (theranostic agents)73. The 
nanoparticles can be prepared with close control of composition, size, shape, 
magnetization, relaxivity and surface charge. Although still at an early stage in their 
development, some of these materials have a realistic potential to translate to the 
clinic. 
 
Ninjbadgar and Brougham74 surface-coated Fe3O4 magnetic nanoparticles with 
aggregation-preventing (3-glycidyloxypropyl)trimethoxysilane and then employed 
ring-opening coupling reactions to coat the epoxy-functionalized materials with 
aminated polymers (polyetheramines) and small molecules (e.g. arginine). The 
resulting stable nanoparticles had exceptionally high spin-lattice relaxivity (r1) 
values, offering a potential use as MRI contrast agents. 
 
Cao and co-workers49 prepared a superparamagnetic, nanocomposite material 
comprising a Fe3O4/amino-silane core and pendant cyclodextrins (Fe3O4-MNPs-
pAPTES-CD) (Figure 17). They postulated applications including magnetically-
responsive drug delivery vehicles and bioseparation technology. 
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Figure 17. Schematic for formation of cyclodextrin-functionalised , silicon-coated 
magnetic nanoparticles (Fe3O4-MNPs-pAPTES-CD)49. 
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1.5 Microbial Infections 
 
 
1.5.1 Infectious Diseases and Microorganisms 
 
Infectious diseases (Figure 18) can be caused by the following classes of 
microorganisms41,75. 
 
 Bacteria - These one-cell organisms are responsible for illnesses, such as strep 
throat, urinary tract infections and tuberculosis.  
 Fungi - Many skin diseases, such as ringworm and athlete's foot, are caused by 
fungi. Other types of fungi can infect the lungs and the nervous system. 
 Viruses - Even smaller than bacteria, viruses cause a multitude of diseases such 
as the common cold, shingles and acquired immune deficiency syndrome 
(AIDS). 
 Parasites - Malaria and Leishmaniasis are caused by tiny parasites that are 
transmitted by mosquito and sandfly bites, respectively. Other parasites may 
be transmitted to humans from animal faeces. 
 
Different pathogens have different modes of transmission. For example, respiratory 
pathogens are usually airborne and intestinal pathogens are normally spread by 
water or food. Drinking water that is contaminated by human or animal faeces, is 
likely to contain disease-causing microbes. 
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(a) (b) 
  
(c) (d) 
Figure 18. Examples of (a) Strep throat – bacterial76, (b) Athlete’s foot – fungal77, (c) 
Shingles rash – viral78 and (d) Leishmaniasis – parasitic79 infections in humans. 
 
Clean water, hygiene and good sewerage systems prevent the spread of water-borne 
diseases such as typhoid and cholera. Inanimate objects such as bedding, towels, toys 
and barbed wire can carry disease-causing organisms. For example, the Trichophyton 
fungus, which causes athlete’s foot, can be spread indirectly through towels and 
changing room floors. Germs can linger on table tops, doorknobs or faucet handles 
and be transmitted directly to a person who touches them. 
 
Some of the more common human diseases and infections and their causative 
microorganism are listed in Table 280. 
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Table 2. Common human diseases and infections and their microbial causes80. 
 
Ailment Bacteria Fungus Protozoa Virus 
Athlete’s foot  x   
Common cold    x 
Diarrheal diseases X    
Flu    x 
Genital herpes    x 
Meningitis x   x 
Pneumonia x x  x 
Shingles    x 
Sinusitis x x   
Skin diseases x x x x 
Strep throat x    
Tuberculosis x    
Urinary tract infection x    
Vaginal infection x x x  
 
According to healthcare experts, infectious diseases caused by microbes are 
responsible for more deaths worldwide than any other single cause41,75. In the United 
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States alone, the estimated annual cost for medical care for treating infectious 
diseases is around $120 billion. Coupled with the crisis of the continuous emergence 
of highly drug-resistant microbial strains81 there is an urgent demand for the 
development of new therapeutics. 
 
1.5.2 Candida albicans 
 
Fungal infection (mycosis) can either be cutaneous or systemic. Opportunistic 
mycosis results from a change in the biochemistry of the host, enabling proliferation 
of a commensal organism, such as C. albicans. Of the seven major Candida species, 
C. albicans is the most virulent82. This opportunistic fungal pathogen is polymorphic 
and changes its morphological structure between yeast, pseudohyphae and hyphae 
forms83 (Figure 19). 
 
Figure 19. Yeast, pseudohyphae and true hyphae forms of C. albicans84. 
 
Infection by C. albicans follows colonisation of the skin, mucosa and gastro-intestinal 
tract. Although C. albicans is generally a harmless commensal, patients undergoing 
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antibiotic therapy and those who are immunocompromised can succumb to 
candidiasis (Figure 20). Indeed, oral/pharyngeal candidiasis is considered a marker 
for the onset of AIDS in human immunodeficiency virus (HIV+) patients, and oral 
cancer patients85. C. albicans cells are frequently found in biofilm-related 
infections86. 
 
Figure 20. C. albicans cutaneous oral infection(thrush)87.  
 
Candida species are becoming increasingly resistant to organic antifungal drugs and 
this resistance leads to greater healthcare costs. Since ca. 1970, the annual death 
rate due to candidiasis has increased and this has generally been attributed to a 
number of factors such as patients undergoing immunosuppressant drug therapies, 
indiscriminate use of antibacterial agents and long term use of catheters88. The 
duration of treatment can also be a factor, with increasing risk of infection linked to 
duration of hospital confinement89. 
 
Currently prescribed fungistatic azole drugs such as miconazole and fluconazole 
(Figure 21), target the biosynthetic pathway of ergosterol, the main cell wall 
component in both the yeast and filamentous forms of C. albicans90. The polyene 
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drugs, such as amphotericin B (Figure 21) and nystatin, are fungicidal and damage 
the plasma membrane by essentially dissolving out the vital ergosterol present in the 
membrane91. Amphotericin B is severely nephrotoxic92 and  azole drugs can cause 
endocrine problems in mammals due to inhibition of cytochrome P45093.  
 
  
(a) (b) 
 
(c) 
Figure 21. Azole drugs (a) fluconazole and (b) miconazole and (c) the macrocyclic 
polyene drug, amphotericin B. 
 
Previous studies on Candida species have shown that metal ions, including copper(II), 
block or cause the transition between different yeast morphologies94, and can kill the 
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organism95. Copper(II)-complexed 1,10-phenanthroline (phen) ligands (Figure 22) 
have been found to damage mitochondrial function and inhibit respiration in fungi96, 
and phen co-complexed with malonic acid and chelated to copper(II) was shown to 
have good activity with respect to inhibition of the growth of C. albicans97.  
 
 
Figure 22. Copper(II) ion chelated by 1,10-phenanthroline (phen). 
 
Copper ions are known to have an affinity for sulphur and nitrogen-containing 
molecules and this may affect proteins containing these particular donor atoms98. 
Inorganic derivatives of phen-based compounds may have applications with respect 
to fungal inhibition due to the fact that their mode of inhibition is different to that of 
the organic antifungal prescription drugs99. Metal-free phen also has potent 
antifungal activity, and it is assumed that the bio-active N,Nˊ chelating base 
sequesters trace metals from either the growth media or from metalloproteins 
associated with the organism, and that the resulting metal-phen complexes are the 
active species100. In complexes where phen was replaced by 2,2'-bipyridine (bipy), 
only very minimal anti-Candida activity was observed97. Manganese(II)-phen 
complexes have been shown to damage mitochondrial function and respiration101. 
Interestingly, Candida specimens treated with copper(II)-phen complexes showed 
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reduced ergosterol levels, whilst the equivalent manganese(II) complexes caused an 
increase in the amount of ergosterol. Levels of respiratory cytochromes b and c 
(which are components of the electron transport chain in mitochondria) in Candida 
cells decreased upon administration of copper(II) and manganese(II)-phen 
complexes.  
 
1.6 Copper Chemistry and Biological Activity 
 
 
1.6.1 General Copper Chemistry 
 
Copper is positioned in the d-block in the Periodic Table and is a soft, malleable metal 
with a reddish-orange tarnish. Although some natural deposits of metallic copper 
have been found, it is generally mined either as a sulphide (e.g. covellite (CuS), 
charlcocite (Cu2S) and bornite (Cu3FeS3)), or as a hydroxide (e.g. malachite 
Cu2CO3(OH)2), silicate (e.g. chrysocolla, CuSiO3.2H2O), or sulphate (e.g. chalcanthite 
CuSO4.5H2O))102. 
 
 
1.6.2 Coordination Chemistry of Copper 
 
Metallic copper has the electronic configuration [Ar] 3d104s1 and the copper(II) 
oxidation state, [Ar] 3d94s0, is the most common. The complex salt, Cs2[CuCl4], has 
the copper(II) ion at the centre of a tetrahedron and in [EtNH3]2[CuCl4] the metal has 
square-planar coordination geometry. [Cu(bipy)2I]+ and [{Cu(dimethylglyoxime)2}] 
have trigonal bipyramidal and square-pyramidal structures, respectively, whilst the 
copper(II) ion has an octahedral coordination geometry in K2Pb[Cu(NO2)6]103.   
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1.6.3 Biological Activity of Copper Ions 
 
The fact that copper ions are essential for life was first recognised in 1928104. Copper 
ions are present in all plants and animals and are also found in a variety of enzymes 
such as superoxide dismutase and cytochrome c oxidase105. As the third most 
abundant natural trace metal element in the body, after iron and zinc, it is found in 
varying concentrations (from a few ppm to several hundred ppm) in all organs and 
tissues of the human body106. In the body, it is not normally found as a free copper 
ion but rather as bonded to cellular proteins and organic compounds107. Dietary 
sources of copper are food (e.g. leafy greens, nuts, whole grains, oysters etc.), 
drinking water and copper-containing supplements, and the estimated adult daily 
intake from food is 1.0-1.3 mg/day (0.014-0.019 mg kg-1/day)107. Copper-containing 
ointments are said to be beneficial due to the fact that copper(II) ions are necessary 
for promoting the growth of endotheilial cells and also for the stabilisation of skin 
proteins108. Small amounts of the ions can be acquired through a reaction between 
metallic copper and sweat (by wearing a copper bracelet) or by topical application of 
ointments containing a high concentration of copper(II) ions (Figure 23)109. 
  
(a) (b) 
Figure 23. (a) A copper bracelet110, and (b) a copper(II)-containing, commercially 
available wound ointment for topical application111. 
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1.6.4. History of the Medicinal Uses of Copper 
 
The biocidal use of copper has been known since ca. 2000 B.C. when the ancient 
Egyptians used it to sterilise water and wounds112. Since then, copper has been 
prescribed for a sore throat, boils, skin and eye infections113 as well as lung disease114. 
From 1761, when it was found that soaking seed grains in aqueous CuSO4 inhibited 
fungal growth, copper has been widely utilised for its antimicrobial properties. In the 
1880s, a combination of CuSO4, lime and water, referred to as the Bordeaux mixture 
(Figure 24), and a blend of CuSO4 and sodium carbonate, known as the Burgundy 
mixture, became popular fungicides for prevention of infection in grapes and vines. 
  
(a) (b) 
 
 
Figure 24. (a) Bordeaux mixture and (b) Bordeaux mixture on the surface of vines and 
grapes. 
 
Copper ions are still used extensively today for their antimicrobial properties and 
they can kill a wide spectrum of yeast and fungi (e.g. Aspergillus carbonarius, C. 
albicans, Saccharomyces cerevisiae), bacteria (e.g. Escherichia coli, Listeria 
monocytogenes, Staphylococcus epidermidis) and viruses (e.g. Poliovirus, Human 
Immunodeficiency Virus Type 1 (HIV-1), Influenza A) The US Environmental 
Protection Agency has verified the beneficial use of antimicrobial copper as a touch 
surface material, supporting the claim of the continuous kill of >99.9% of bacteria 
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that come in contact with the metal within a period of two hours112. In addition to 
bacteria, copper surfaces also have antifungal and antiviral properties36. Copper 
metal has been incorporated into a number of household items such as cabinet 
handles, cistern handles, dressing trolleys, taps and bed rails (Figure 25)35,39. In all 
cases, it is the copper(II) cation, and not the atom (copper(0)), which is responsible 
for the bioactivity. 
 
   
(a) (b) (c) 
Figure 25. (a) A copper sink, (b) a copper door handle, and (c) copper covered light 
switch panel.  
 
In an attempt to prevent nosocomial infection, CuO has been incorporated into 
various textiles, such as polyester, polypropylene, polyethylene, polyurethane and 
nylon, which are used in the manufacture of pyjamas, socks, sheets and many other 
items115. Encouragingly, reports of resistance to copper are somewhat rare116. There 
are numerous references to copper-based, non-steroidal, anti-inflammatory drugs 
offering reduced gastrointestinal toxicity when compared to the parent, non-metal 
constituents117,118. Although there are currently no oral delivered copper-based 
drugs being prescribed, an ethanolic gel-base of copper-salicylate (Alcusal®) is 
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frequently used as a topical treatment for the relief of pain and inflammation119. A 
solution of copper(II) naphthenate (Kopertox®) is used for the treatment of equine 
thrush120 and copper(II) glycinate121 is injected into cattle to prevent copper 
deficiency. A DMSO solution of copper(II) salicylate (Dermcusal®) is topically applied 
as an anti-inflammatory and anti-arthritic agent for animals122. 
 
The toxicity of the copper ion is thought to be due to the generation of reactive 
oxygen species (ROS), which occurs during the redox cycling between the copper(I) 
and copper(II) oxidation states (equations below)123. Reduction of copper(II) to 
copper(I) in the presence of superoxide is followed by the re-oxidation to copper(II) 
by hydrogen peroxide and the generation of highly toxic hydroxyl radicals124. 
 
Cu(II) + O2-.    Cu(I) + O2      (4) 
Cu(I) + H2O2   Cu(II)  + OH- + OH·     (5) 
 
Acute copper toxicity is rare and is mostly confined to young children who have 
accidently swallowed copper solutions. Copper salts are powerful emetics (induce 
vomiting) and so large doses are rejected by the body. However, copper poisoning 
can result in severe liver disease and neurological defects125. Wilson’s disease is a 
disorder of copper metabolism and is characterised by the accumulation of copper(II) 
ions in various organs, resulting in liver cirrhosis, neurological disturbances and also 
a range of symptoms related to the disruption of copper transport systems in the 
body126. Metal ion chelator ligands containing nitrogen donor atoms, such as 
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triethylenetetramine (Figure 26), can bind copper(II) ions and are used to remove 
excess systemic copper in Wilson’s disease and in some cases of diabetes mellitus127.   
 
 
 
Figure 26. Structure of triethylenetetramine. 
 
Menkes disease is an X-linked inherited chromosome disorder that causes severe 
prenatal and postnatal copper deficiency in males. This causes brain damage and 
intellectual development disorders, a scalp-hair defect (kinky hair syndrome), fragile 
bones, aortic aneurisms and other conditions128. Copper ions have also been 
implicated in other neurodegenerative diseases such as Alzheimer’s, familial 
amyotrophic lateral sclerosis and Creutzfeldt-Jakob disease125.   
 
The potent antimicrobial properties of copper(II), coupled with its relatively low 
toxicity towards mammalian cells, prompted its use in the present research work. 
The present study aims to incorporate antimicrobially active copper(II) ions into 
water-insoluble silicone polymers and also into silicone polymers that have been 
anchored onto the surface of Fe3O4 magnetic nanoparticles.  
 
  
 
CHAPTER 2 
 
Experimental 
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2.1 General Methodology 
 
 
2.1.1 Chemicals 
Chemicals were obtained from commercial sources and, unless specified, were used 
without further purification.  
 
2.1.2 Infrared Spectroscopy 
Infrared spectra were obtained using a Perkin Elmer 2000 FT-IR spectrophotometer. 
KBr discs were used for all spectra. 
 
2.1.3 1H NMR Spectroscopy 
NMR (δ ppm; J Hz) spectra were recorded for soluble compounds on a Bruker Avance 
300 MHz NMR spectrometer and also on a Bruker AVII500 500 MHz NMR 
spectrometer using saturated CDCl3 solutions with Me4Si reference, unless indicated 
otherwise, with resolutions of 0.18 Hz and 0.01 ppm. 
 
2.1.4 Scanning Electron Microscopy and Energy Dispersive X-ray 
Scanning Electron Microscopy (SEM) and Energy Dispersive X-ray (EDX) analyses were 
carried out on a Hitachi S-3200N Scanning Electron Microscope. The selected samples 
were mounted on carbon tabs. In the present study, EDX analysis of selected samples 
was carried out in order to qualitatively assess the elements present in the sample. 
It should be noted that EDX analysis does not directly correlate with the total carbon 
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and metal content of a sample as determined by microanalysis. EDX analysis will only 
provide data relevant to the sample surface and the layer just immediately below the 
surface (which can be penetrated by the electron beam), whereas microanalysis is 
for the total bulk sample. 
 
2.1.5 Transmission Electron Microscopy  
Transmission Electron Microscopy (TEM) images were obtained using a Hitachi H-
7650 at the Royal College of Surgeons in Ireland, 123 St. Stephen’s Green, Dublin. The 
samples were prepared on 400 mesh copper grids coated with Formvar film. The 
MNPs were suspended in ethanol, dropcast onto the grids and dried at ambient 
temperature. 
 
2.1.6 Acetone Piston 
Prepared samples were dried in a drying piston under vacuum at the temperature of 
refluxing acetone (56.5 °C). 
 
2.1.7 Microanalytical Data 
Microanalytical data were obtained using a Flash EA CHN Analyser.  
 
Although the mass yield of polymeric products have been given the % yields have not 
been stated as the materials have generally an appreciable amount of encapsulated 
reaction solvent and/or washing solvent. 
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2.1.8 Solvents 
Solvents used for solubility tests were water, ethanol, methanol, chloroform, 
dichloromethane (DCM), dimethylsulfoxide (DMSO), toluene, acetonitrile and 
dimethylformamide (DMF). 
 
2.1.9 Sonication 
For reactions in which samples were dissolved/suspended via sonication, a Branson 
1510 sonicator bath was used. 
 
2.1.10  Sterilisation of Microbiological Media and Equipment 
A Dixons ST228 autoclave was used to sterilise the microbiological media and 
equipment at 121 °C and 124 kPa for 20 minutes. 
 
2.1.11  Antimicrobial Assays 
Candida albicans ATCC 10231 was obtained from the American Type Culture 
Collection (Manasas, VA, USA). For the antifungal testing, all work surfaces were 
washed with ethanol/water 70% (v/v) and a Bunsen flame was used to sterilise the 
immediate atmosphere while the C. albicans cells were plated, at a concentration of 
1 x 10-6 cells cm-3, onto pre-sterilised yeast extract peptone dextrose (YEPD) growth 
medium contained in petri dishes129. The petri dishes were incubated for 0.5 h at 37 
°C. Three separate portions of each individual solid test sample were added and the 
plate then incubated for 20 h at 37 °C. The degree of fungal growth inhibition was 
visualised, photographed and the results tabulated.  
     
~ 44 ~ 
 
2.1.12  MNP Separation 
Freshly prepared Fe3O4 magnetic nanoparticles were separated from suspension 
using a neodymium-iron alloy magnet, N52 NdFeB + NiCuNi (size 50 x 50 x 25 mm), 
supplied by Magnet Expert Ltd. (code F335-N52). The magnet was placed under the 
reaction flask and the MNPs were held at the bottom of the flask. The mother liquor 
was decanted off and the MNPs were washed several times with ethanol and then 
dried in a vacuum desiccator. Samples of polymer-coated magnetic nanoparticles, 
which could not be efficiently separated from suspension using the neodymium-iron 
alloy magnet, were recovered by centrifugation at 10,000 rpm (14.336 x g) using a 
Beckman Coulter Optima L-100 XP Ultra centrifuge and then washed with either 
ethanol or methanol and dried in a vacuum desiccator. 
 
2.1.13  Structural Diagrams 
 
Where structural diagrams are given for polymeric species these are only one of a 
number of structural possibilities.  
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2.2 Fe3O4-MNPs 
 
Fe3O4 magnetic nanoparticles were made using the following co-precipitation 
literature method43. FeCl3.6H2O (11.68 g, 43.21 mmoles) and FeCl2.4H2O (4.60 g, 21.60 
mmoles) were dissolved with stirring in deoxygenated millipore water (200 mL) and 
under flowing N2 gas. The pH of the suspension was pH 0.6 and the temperature was 
raised to 85 °C. Following 0.5 h of mechanical stirring, a single portion of NH4OH (15 
mL, 25% v/v) was added, causing an immediate precipitation of a black material and 
a resulting change in the pH of the suspension to pH 8. This suspension was stirred 
for a further 0.5 h and then cooled to room temperature. The black precipitate was 
separated using magnetic decantation, washed twice with millipore water and once 
with aqueous NaCl (0.02 M) followed by a final wash with millipore water. The solid 
was dried in a vacuum desiccator and stored in a desiccator. 
 
Yield: 4.60 g, 92 %. 
IR (KBr, cm-1): 3385 (H-O-H stretch), 1631 (H-O-H bend), 1399, 1012, 800-400 
(Fe-O). 
 
 
2.3 pAPTES 
 
mAPTES was polymerised in accordance with the patented procedure24. mAPTES 
(2.00 g, 9.03 mmoles) was added dropwise to water (50 mL) and the resulting clear 
solution was left stirring overnight at room temperature. The solvent was removed 
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under reduced pressure. A colourless crystalline solid was recovered and this was 
washed with ice-cold water and ice-cold ethanol on a sintered glass funnel. This 
washing procedure was repeated three times. The glass-like flakes were then dried 
under vacuum at 56 °C. 
 
Soluble in H2O, EtOH and MeOH 
Yield:  0.91 g. 
IR (KBr, cm-1):  3600-3200 (H-O-H and H-N-H), 2932-2875 (C-H), 1700-1500 
(H-O-H and H-N-H), 1474 (C-C), 1200-900 (Si-O-Si), 749 (Si-C). 
1H NMR (ppm, D2O)δ: 2.76 (m, Hc), 1.57 (m, Hb), 0.46 (m, Ha). 
Anal. Found:  C 26.48%, H 6.76%, N 9.40%.  
 
 
2.4 pAPTES-Fe3O4-MNPs 
 
pAPTES-modified Fe3O4 magnetic nanoparticles (pAPTES-Fe3O4-MNPs) were made in 
accordance with a reported literature method49. Fe3O4-MNPs (0.300 g, 1.290 
mmoles) were ground to a fine powder using a mortar and pestle, and then dispersed 
in a mixture of ethanol (600 mL) and water (4 mL) by sonication. To the resulting 
suspension was added monomeric (3-aminopropyl)triethoxysilane (mAPTES) (120 µL, 
0.122 g, 0.551 mmoles) using a micropipette. The mixture was sonicated at room 
temperature for 0.25 h and then mechanically stirred for 7 h. The suspension was 
separated by centrifugation (10,000 rpm (14.336 x g)) and then re-dispersed by 
sonication in fresh ethanol and then separated again using magnetic decantation. 
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This re-dispersion/decantation process was repeated a further five times. The black 
pAPTES-Fe3O4-MNPs were dried in a vacuum desiccator and stored in a desiccator. 
 
Yield: 0.250 g. 
IR (KBr, cm-1): 3404 (H-O-H stretch), 1625 (H-O-H bend), 1511, 1150-900 (Si-O-Si), 
800-400 (Fe-O).  
Anal. Found: C 1.90%; H 0.70%, N 0.39%. 
 
 
2.5 [(NO3)2Cu-pAPTES]      
  
[(NO3)2Cu-pAPTES] was synthesised using a published procedure129. mAPTES (125 µL, 
0.118 g, 0.534 mmoles) was added dropwise to a solution of Cu(NO3)2.3H2O (0.280 g, 
1.158 mmoles) in water (5 mL). The resulting blue solution was stirred overnight. The 
solvent was removed under reduced pressure. The blue solid was washed three times 
with ice-cold water and three times with ice-cold ethanol on a sintered glass funnel. 
The royal blue, glass-like flakes were dried under vacuum at 56 °C.  
 
Insoluble in all common solvents. 
Yield:  0.136 g. 
IR (KBr cm-1):  3700-3100 (H-O-H and H-N-H), 2930 (C-H), 1700-1600 (H-O-H and 
H-N-H), 1384 (NO3), 1200-900 (Si-O-Si). 
Anal. Found: C 18.53%, H 4.35%, N 10.52%.  
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2.6 [(OAc)2Cu-pAPTES-Fe3O4-MNPs]   
 
pAPTES-Fe3O4-MNPs (0.15 g) were sonicated until finely dispersed in ethanol (200 
mL). To this suspension was added a solution of [Cu2(OAc)4(H2O)2] (0.05 g, 0.125 
mmoles) in ethanol (15 mL). The mixture was sonicated for 0.5 h and then stirred 
mechanically for 1 h. The resulting suspension was decanted magnetically and 
washed with fresh ethanol. This re-dispersion/decantation process was repeated a 
further three times. The black powder was dried in a vacuum desiccator and then 
stored in a desiccator. 
 
Yield:  0.03 g. 
IR (KBr, cm-1): 3422 (H-O-H and H-N-H), 2923 (C-H), 1700-1500 (H-O-H, H-N-H and 
O-C-O), 1385 (O-C-O), 1200-1000 (Si-O-Si), 700-450 (Fe-O). 
Anal. Found: C 1.63%, H 0.41%, N 0.29%. 
 
2.7 SalH-pAPTES 
 
method (a) – using mAPTES  
 
Salicylaldehyde was added to mAPTES using a modified literature procedure129. 
Salicylaldehyde (0.50 g 4.09 mmoles) was added dropwise to neat mAPTES, (1.00 g, 
4.50 mmoles) while stirring. The viscous yellow solution was stirred for 0.6 h and the 
solvent was then removed under vacuum. The yellow solid was washed with 
methanol three times and dried under vacuum at 56 °C.  
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Insoluble in all common solvents. 
Yield:  0.43 g. 
IR (KBr, cm-1):  3366 (H-O-H and H-N-H), 2932 (aliphatic C-H), 1634 (C=N), 1600-
1500 (H-O-H and H-N-H),  1200-900 (Si-O-Si). 
Anal. Found:  C 31.79%, H 6.57%, N 9.80%. 
 
method (b) – using pAPTES  
 
pAPTES, (1.00 g,  4.50 mmoles) was ground to powder using a pestle and mortar. To 
this was added salicylaldehyde (0.50 g, 4.09 mmoles) dropwise while stirring. The 
viscous yellow solution was stirred for 0.6 h and then evaporated under vacuum. The 
yellow  solid  was  washed with  methanol three  times and dried under vacuum at  
56 °C.  
 
Insoluble in all common solvents. 
Yield: 0.47 g. 
IR (KBr, cm-1):   3433 (H-O-H and H-N-H), 3100 (aromatic C-H), 2932 (aliphatic C-
H), 1634 (C=N), 1600-1500 (H-O-H and H-N-H),  1200-900 (Si-O-Si). 
Anal. Found:  C 47.58%, H 5.83%, N 7.30%. 
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2.8 SalH-pAPTES-Fe3O4-MNPs 
 
pAPTES-Fe3O4-MNPs (0.15 g) were sonicated in ethanol (200 mL) until finely 
dispersed. To this suspension was added, dropwise, a solution of salicylaldehyde 
(0.08 g, 70 µL, 0.65 mmoles) in ethanol (20 mL). Sonication was continued for ca. 5 
minutes, followed by mechanical stirring for 3.5 h. The particles were separated by 
magnetic decantation and then re-dispersed in fresh ethanol. This re-
dispersion/decantation process was repeated a further five times. The brown 
powder was dried in a vacuum desiccator and then stored in a desiccator. 
 
Yield: 12.0 g. 
 IR (KBr, cm-1): 3402 (H-O-H stretch), 1623 (C=N), 1566 (H-O-H bend), 1411, 1300-
1000 (Si-O-Si), 750-450 (Fe-O).  
Anal. Found: C 3.25%, H 0.47%, N 0.08%. 
 
2.9 [Cu-Sal-pAPTES-Fe3O4-MNPs]       
 
A solution of [Cu2(OAc)4(H2O)2] (0.05 g, 0.12 mmoles) in ethanol (15 mL) was added 
dropwise to Sal-pAPTES-Fe3O4-MNPs (0.12 g) dispersed by sonication in ethanol (200 
mL). The mixture was sonicated for a further 10 min and then placed on a mechanical 
stirrer for 2 h. The Cu-Sal-pAPTES-Fe3O4-MNPs were separated using magnetic 
decantation and washed with fresh ethanol. This process was repeated 5 times. The 
brown powder was dried in a vacuum desiccator and stored in a vacuum desiccator. 
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Yield: 0.08 g. 
IR (KBr, cm-1):  3402 (H-O-H stretch), 2918 (aliphatic C-H), 1626 (C=N), 1567 cm-1 
(H-O-H bend), 1411, 1300-1000 (Si-O-Si), 750-450 (Fe-O). 
Anal. Found:  C 1.22%, H 0.23%, N 0.17%. 
 
2.10 pTMSPDT 
 
mTMSPDT was polymerised to form pTMSPDT by modifying a literature procedure129. 
mTMSPDT (0.50 g, 1.88 mmoles) was added dropwise to water (50 mL) whilst stirring. 
The colourless solution was stirred overnight at room temperature. The solvent was 
completely removed under vacuum to give a colourless, crystalline solid. The solid 
was washed with ice-cold water and then ice-cold methanol. This washing process 
was repeated three times. The glass-like crystal flakes were then dried under vacuum 
at 56 °C. 
 
pTMSPDT was sparingly soluble in warm H2O only. 
Yield: 0.31 g. 
IR (KBr, cm-1): 3600-3100 (H-O-H and H-N-H and N-H), 2934 (C-H), 1700-
1500 (H-O-H and H-N-H), 1473 (C-C), 1200-950 (Si-O-Si), 772 
(Si-C). 
1H NMR (ppm, D2O):δ  2.77 (m, Hc-g), 1.62 (m, Hb), 0.54 (t, Ha). 
Anal. Found: C 39.04%, H 8.16%, N 18.06%. 
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2.11 pTMSPDT-Fe3O4-MNPs 
 
pTMSPDT-modified Fe3O4 magnetic nanoparticles (pTMSPDT-Fe3O4-MNPs) were 
made using an amended literature method49. Fe3O4-MNPs (0.300 g, 1.290 mmoles) 
were ground to a fine powder using a mortar and pestle, and then dispersed by 
sonication in a mixture of methanol (600 mL) and water (4 mL). To the resulting 
suspension was added mTMSPDT (129 µL, 0.124 g, 0.467 mmoles). The mixture was 
sonicated for 0.25 h and then mechanically stirred for 2 h. The black product was 
removed from the solvent using magnetic decantation. The product was then re-
dispersed using sonication in fresh methanol. This re-dispersion/decantation process 
was repeated a further three times. The black solid was dried in a vacuum desiccator 
and then stored in a desiccator. 
 
Yield: 0.200 g. 
IR (KBr, cm-1): 3401 (H-O-H stretch), 2933 (C-H), 1620 (H-O-H bend), 1511, 1300-
1100 (Si-O-Si), 800-450 (Fe-O). 
Anal. Found:  C 2.76%; H 0.68%, N 0.75%. 
 
 
2.12 [(NO3)2Cu-pTMSPDT]  
 
method (a) – using mTMSPDT 
 
mTMSPDT (0.25 g, 0.94 mmoles) was added dropwise to a solution of Cu(NO3)2.3H2O 
(0.46 g, 1.90 mmoles) in water (5 mL). The solution was stirred for 4 h and then the 
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solvent was removed under reduced pressure. The solid was recovered by filtering 
through a sintered glass funnel. The royal blue coloured flakes were washed with ice-
cold millipore water and methanol, and dried under vacuum at 56 °C. 
 
Yield:  0.04 g. 
IR (KBr cm-1):  3600-3000 (H-O-H and H-N-H and N-H), 2917 (C-H), 1700-1550 (H-
O-H and H-N-H), 1384 (NO3), 1200-850 (Si-O-Si). 
Anal. Found:  C 19.43%, H 4.69%, N 16.55%. 
 
method (b) – using pTMSPDT 
 
Powdered pTMSPDT (0.13 g) was added to a solution of Cu(NO3)2.3H2O (0.46 g, 1.90 
mmoles) in water (5 mL). The suspension was stirred for 4 h. The solvent was 
removed under reduced pressure and the royal blue crystal flakes were washed with 
ice-cold millipore water and methanol and dried under vacuum at 56 °C. 
 
Yield:  0.03 g. 
IR (KBr cm-1): 3700-3100 (H-O-H and H-N-H and N-H), 3000-2800 (C-H), 1700-
1550 (H-O-H and H-N-H), 1384 (NO3), 1150-950 (Si-O-Si). 
Anal. Found: C 16.98%, H 4.03%, N 13.28%. 
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2.13 [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] 
 
pTMSPDT-Fe3O4-MNPs (0.017 g) were dispersed by sonication in methanol. To this 
suspension was added a solution of [Cu2(OAc)4(H2O)2] (0.060 g, 0.15 mmoles) 
dissolved in methanol (15 mL) and the mixture was sonicated for 1 h. The solid 
particles were magnetically decanted and washed with fresh methanol. This 
washing/decantation process was repeated three times. The black powder was 
separated using magnetic decantation and dried in a vacuum desiccator. 
 
Yield: 0.010 g. 
IR (KBr, cm-1):  3420 (H-O-H, H-N-H and N-H), 2918 (C-H), 1700-1500 (H-O-H, H-N-
H and O-C-O), 1384 (O-C-O), 1300-1000 (Si-O-Si), 700-450 (Fe-O). 
Anal. Found:  C 10.42%, H 0.49%, N 0.43%. 
 
 
2.14 SalH-pTMSPDT 
 
SalH-pTMSPDT was prepared according to a literature procedure129. Salicylaldehyde 
(SalH) (0.50 g, 4.09 mmoles) was added dropwise to a solution of mTMSPDT (1.05 
mL, 1.09 g, 4.10 mmoles) in water (2 mL) and the solution went yellow. The yellow 
solution was stirred for 40 min. The solvent was removed under reduced pressure 
and the yellow solid product was washed with methanol and then dried under 
vacuum at 56 °C. 
 
Insoluble in all common solvents. 
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Yield:  1.00 g. 
IR (KBr, cm-1): 3420 (H-O-H, H-N-H and N-H), 3048 (aromatic C-H), 3000-2800 
(aliphatic C-H), 1633 (C=N), 1583 (H-O-H and H-N-H),  1200-900 (Si-
O-Si). 
Anal. Found: C 55.99%, H 6.82%, N 12.72%. 
 
2.15 SalH-pTMSPDT-Fe3O4-MNPs 
 
pTMSPDT-Fe3O4-MNPs (0.020 g) were sonicated in methanol (200 mL) until finely 
dispersed. To this suspension was added, dropwise, a solution of salicylaldehyde 
(SalH) (0.070 µL, 0.008 g, 0.066 mmoles) in methanol (20 mL). Sonication was 
continued for ca. 5 min, followed by mechanical stirring for 0.6 h. The particles were 
decanted magnetically and then re-dispersed in fresh methanol. This re-
dispersion/decantation process was repeated a further five times. The brown 
powder was dried in a vacuum desiccator and then stored in a desiccator. 
 
Yield: 0.015 g. 
IR (KBr, cm-1): 3434 (H-O-H, H-N-H and N-H), 2929 (aliphatic C-H), 1636 (H-O-H 
and H-N-H), 1350-1070 (Si-O-Si), 790-450 (Fe-O). 
Anal. Found:  C 8.65%, H 0.53%, N 0.51%. 
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2.16 [Cu-Sal-pTMSPDT-Fe3O4-MNPs]  
 
[Cu2(OAc)4(H2O)2] (0.15 g, 0.38 mmoles) was dissolved in methanol and added 
dropwise to a sonicated, methanolic dispersion of SalH-pTMSPDT-Fe3O4-MNPs (0.29 
g). The suspension was sonicated for a further 0.25 h and then placed on a 
mechanical stirrer for 1 h. The solid product was separated using magnetic 
decantation and washed with fresh methanol. This re-dispersion/decantation 
process was repeated 5 times. The black powder was dried in a vacuum desiccator 
and stored in a desiccator. 
 
Yield:   0.20 g. 
IR (KBr, cm-1): 3413 (H-O-H, H-N-H and N-H), 2925 (aliphatic C-H), 1636 (H-O-H 
and H-N-H), 1350-1100 (Si-O-Si), 800-460 (Fe-O). 
Anal. Found: C 5.32%, H 0.52%, N 0.51%. 
 
 
 
 
 
 
 
     
 
 
CHAPTER 3 
 
Results and Discussion 
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This Results and Discussion section is configured to give the reader a general 
overview of the structural characterisation of the silicone polymers, their salicylate 
Schiff base derivatives and their Cu(II) complexes. Due to the insoluble nature of most 
of the compounds, the structural characterisation is extrapolated from a 
combination of IR, CHN and EDX data. Results of in vitro testing of the compounds 
against the fungal species, Candida albicans, are presented and discussed.  
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3.1 Fe3O4-MNPs 
 
3.1.1 Fe3O4-MNPs 
 
Black Fe3O4 magnetic nanoparticles (Fe3O4-MNPs) were prepared in good yield by 
using a literature co-precipitation method43. The IR spectrum of Fe3O4-MNPs (Figure 
27) contains a cluster of strong Fe-O bands in the region 800-400 cm-1 which are 
comparable with the previously reported literature values43,52. The bands at 634 and 
584 cm-1 are assigned to splitting of the Fe-O 570 cm-1 band which occurs in the 
spectrum of ‘bulk’ magnetite. The Fe-O 375 cm-1 band in ‘bulk’ magnetite shifts to 
443 cm-1 in the spectrum of nanoparticulate Fe3O4. The presence of a strong H-O-H 
stretching band centered around 3385 cm-1 and a weak H-O-H bending vibration at 
1631 cm-1 indicates that the Fe3O4-MNPs are hydrated. 
 
 
Figure 27.  IR spectrum of hydrated Fe3O4-MNPs.  
 
A representation of the structure of Fe3O4-MNPs is shown in Figure 28. 
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Figure. 28. A schematic representing the structure of Fe3O4-MNPs (incorporated H2O 
molecules not shown).  
 
The surface morphology of Fe3O4-MNPs was studied using SEM (Figure 29). The lower 
magnification image shows smooth surfaces with sharp, angular, stepped ledges 
throughout, while images taken under higher magnification reveal a rough, rippled 
surface and angular ledges.  
 
SEM images of Fe3O4-MNPs from literature sources130,131 (Figure 30) appear to have 
less apparent agglommeration at the lower magnification (10 µm). A dimpled surface 
is visible at the 50 nm magnification. Variations in synthetic protocol such as the  
speed of mechanical stirring used during synthesis may account for these 
differences132. 
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Figure 29. SEM images of Fe3O4-MNPs (synthesised in the present study) at various 
magnifications: (a) 100 µm, (b) 40 µm, (c) 30 µm and (d) 10 µm. 
 
  
(a) (b) 
Figure 30. SEM images of Fe3O4-MNPs (a) 10 µm130, and (b) at high magnification 50 
nm131.  
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When making small molecules, a distribution of sizes is generally obtained43. 
Aggregation of the uncoated, bare Fe3O4-MNPs prepared in the present study is 
observed in the TEM images shown in Figure 31. Such agglomeration is normally to 
be expected as there were no surfactants present during sample preparation133. 
Individual nanoparticles of <20 nm are visible in Figure 31 (b) at a magnification of 
X600,000 at 100 kV.  
 
  
(a) (b) 
Figure 31. TEM images of Fe3O4-MNPs synthesised in the present work at 
magnifications of (a) 100 nm and (b) 20 nm. (Hitachi H7650. 100 kV). 
 
The TEM images obtained for the Fe3O4-MNPs particles prepared in the present study 
are comparable to images available from the literature56 (Figure 32 (a)) and from 
commercial sources134 (Figure 32 (b)). 
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(a) (b) 
Figure 32. TEM and Selected Area Electron Diffraction (SAED) image of (a) Fe3O4-
MNPs56, and (b) high magnification TEM image of Fe3O4-MNPS from a commercial 
website134.       
 
3.2 pAPTES Materials 
 
3.2.1 pAPTES  
 
Emulating the literature method24 of stirring mAPTES in water at room temperature 
gave colourless pAPTES in high yield. Although microanalytical data for pAPTES 
(found: C 26.48%, H 6.76%, N 9.40%) corresponded well with those reported in the 
literature135,136,129, the % elemental composition values were substantially lower than 
those calculated for a pure polymer of formula (C3H8NSiO3/2)n (calc.: C 32.70%, H 
7.32%, N 12.71%). The found %C:%N ratio of 2.8:1 for the present sample of pAPTES 
was slightly higher than that calculated (%C:%N = 2.6:1) for the propylamine 
functionality in pure pAPTES, suggesting the presence of some extra carbon-
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containing species in the pAPTES sample. Indeed, the 1H NMR spectrum of the 
material (discussed below) confirmed the presence of a small quantity of ethyl 
moieties in the sample, possibly due to trapped ethanol from the washing procedure 
and/or ethoxy groups from some unreacted mAPTES. 
 
The IR spectrum of pAPTES (Figure 33) shows the characteristic broad band (1200-
900 cm-1) associated with the Si-O-Si linkage145. The relatively broad bands (3600-
3200 and 1700-1500 cm-1) arise from H-O-H and H-N-H stretching and H-O-H and H-
N-H bending vibrations195 respectively, indicating that there is some trapped water 
and ethanol molecules (see discussion of 1H NMR spectrum) in the pAPTES matrix. 
 
 
Figure 33. IR spectrum of pAPTES. 
 
The 1H NMR (D2O solution) spectrum of pAPTES (Figure 34) shows multiplets at ca. 
0.5, 1.6 and 2.8 ppm for Ha, Hb and Hc, respectively. A triplet and a quartet centred at 
ca. 1.05 and 3.55 ppm indicated the presence of a relatively small quantity of ethyl 
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moieties in the sample, arising from ethanol washing of the product and/or some 
unreacted mAPTES (discussed above). 
 
 
 
Figure 34. 1H NMR (D2O) spectrum of pAPTES. 
 
A schematic representing the structure of pAPTES is shown in Figure 35. 
 
Figure 35. A schematic representing the structure of pAPTES. 
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SEM images of pAPTES are shown in Figure 36 and reveal a relatively smooth, cheese-
like surface morphology. Some bubbling is visible on the block-like polymers which 
probably arises during solvent removal under high vacuum.  
  
Figure 36. SEM images of pAPTES under (a) low magnification and (b) high 
magnification. 
 
3.2.2 pAPTES-Fe3O4-MNPs 
 
Following a literature procedure49, black pAPTES-Fe3O4-MNPs were made by treating 
a suspension of Fe3O4-MNPs in aqueous ethanol with mAPTES (ca. 2.3:1 mole ratio). 
It is known that when Fe3O4 magnetic nanoparticles are dispersed in an aqueous 
medium the surface Fe2+/3+ and O2- ions would adsorb OH- and H+ ions, respectively, 
from self-dissociated H2O molecules (Scheme 1)52. Addition of mAPTES to water 
promotes hydrolysis, ethanol elimination and formation of (OH)3Si(CH2)3NH2. Surface 
-OH moieties on the Fe3O4-MNPs can condense with the –OH groups on 
(OH)3Si(CH2)3NH2 molecules to form Fe-O-Si bonds (Scheme 2). Subsequent 
condensation of neighboring HO-Si functions creates interconnected -O-Si-O-Si- 
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linkages and a polymeric silicone surface coating on the nanoparticles. A schematic 
representation of the structure of pAPTES-Fe3O4-MNPs is shown in Figure 37.  
 
 
Scheme 1. Formation of surface –OH moieties on Fe3O4-MNPs. 
 
 
Scheme 2. Schematic for formation of pAPTES-Fe3O4-MNPs. 
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Figure 37. Representation of the structure of pAPTES-Fe3O4-MNPs. 
 
As expected, the carbon, hydrogen and nitrogen elemental mass composition 
percentages of these elements in pAPTES-Fe3O4-MNPs (found: C 1.90%; H 0.70%, N 
0.39%), which arise from the propylamine functionality in the silicone coating on the 
nanoparticles, were significantly less than those in pAPTES (found: C 26.48%, H 
6.76%, N 9.40%). This is confirmation that the polymer surface coating in pAPTES-
Fe3O4-MNPs represents only a very small proportion of the sample bulk. The finding 
that the %C:%N ratio in pAPTES (2.8:1) is appreciably less than that in pAPTES-Fe3O4-
MNPs (4.87:1), suggests that there may be some non-hydrolysed EtO-Si units from 
mAPTES and/or retention of ethanol (from washings) in the latter material, even 
after prolonged desiccation. These are the only other possible source of additional C 
atoms in the sample which are required to align the high %C:%N ratio. If it is assumed 
that EtOH is the source of additional C atoms then theoretical calculation show that, 
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on average, ca. 1 EtOH is present for each aminopropyl moiety in pAPTES-Fe3O4-
MNPs (gives a %C:%N ratio of 4.29:1)  
 
The IR spectrum of the polymer-coated pAPTES-Fe3O4-MNPs (Figure 38) is very similar 
to that of the uncoated, hydrated Fe3O4-MNPs (Figure 27), with the most prominent 
bands being associated with the H-O-H (3404, 1625 cm-1) and Fe-O (800-400 cm-1) 
vibrations. By comparing the IR spectrum of pAPTES (Figure 33) with that of pAPTES-
Fe3O4-MNPs the occurrence of relatively weak Si-O-Si bands (1150-900 cm-1) confirms 
the presence of the silicone coating in the latter sample. As the amount of silicone 
coating on the surface of the nanoparticles is extremely small in comparison to the 
bulk quantity of Fe3O4-MNPs (confirmed by microanalytical and EDX data) the weak 
C-H stretching bands (ca. 2900 cm-1) and the H-N-H stretching and bending bands 
associated with the aminopropyl function were not clearly discernible in the pAPTES-
Fe3O4-MNPs spectrum. The IR spectra of Fe3O4-MNPs and pAPTES-Fe3O4-MNPs for 
the samples prepared in the present study were very similar to those published by 
Ma et al. for the same materials52. 
 
cm-1 
Figure 38. IR spectrum of pAPTES-Fe3O4-MNPs.  
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The surface morphology of pAPTES-Fe3O4-MNPs was imaged using SEM (Figure 39). 
The sample shows both smooth and granular surfaces.  
 
Figure 39. SEM images of pAPTES-Fe3O4-MNPs. Images (c) and (d) are higher 
magnifications of the rippled regions.  
 
TEM images of pAPTES-Fe3O4-MNPs, synthesised in the present study, (Figure 40) 
show particles of <10 nm in diameter which are well formed and with little apparent 
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agglomeration. These TEM images are very similar to those available from literature 
sources (Figure 41). 
 
 
Figure 40. TEM images of pAPTES-Fe3O4-MNPs at magnification of (a) 500 nm (b) 100 
nm (c) 20 nm (d) 20 nm (Hitachi H7650. 100 kV). 
 
Tem images are very similar to those available from literature sources (Figure 41). 
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Figure 41. TEM image of pAPTES-Fe3O4-MNPs from a literature source52. 
 
A qualitative EDX spectrum of pAPTES-Fe3O4-MNPs (Figure 42) confirmed the 
presence of silicon on the surface of the nanoparticles. An approximate surface 
coverage of APTES on the Fe3O4-MNPs was calculated at 37%, a value that is slightly 
less than that reported in the literature52. This is indicative of a near-monolayer 
surface coating of silicone-polymer on the surface of the Fe3O4-MNPs. 
 
 
Figure 42. EDX spectrum of pAPTES-Fe3O4-MNPs. 
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3.2.3 [(NO3)2Cu-pAPTES]      
 
[(NO3)2Cu-pAPTES] was synthesised using a modified literature procedure129. Royal 
blue, glass-like flakes of [(NO3)2Cu-pAPTES] formed in good yield upon addition of 
Cu(NO3)2.3H2O to mAPTES in water in a ca. 2.2:1 mole ratio. The IR spectrum of the 
product (Figure 43) shows characteristic bands for water and -NH2 functions (3700-
3100 and 1700-1600 cm-1), aliphatic C-H (2930 cm-1), NO3- (1384 cm-1) and Si-O-Si 
moieties (1200-900 cm-1).  
 
 
Figure 43. IR spectrum of [(NO3)2Cu-pAPTES].     
 
The hydrated [(NO3)2Cu-pAPTES] sample returned microanalytical data (found: C 
18.53%, H 4.35%, N 10.52%) which gave a %C:%N ratio of 1.76:1. To achieve this 
%C:%N ratio it has been calculated that, on average, there are ca. 4.5  -CH2CH2CH2NH2 
moieties for every 1 Cu(NO3)2 within solid [(NO3)2Cu-pAPTES] (gives a theoretical 
%C:%N ratio of 1.78:1). If a tentative assumption is made that there is a homogeneous 
distribution of Cu(II) ions throughout the solid, then in some instances there are 4 
CH2CH2CH2NH2 moieties coordinated (by the amine N atom) to the metal centre, 
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whilst at other sites there could be 5 CH2CH2CH2NH2 coordinated to the metal. A 
schematic representing one of the possible structural formats of [(NO3)2Cu-pAPTES] 
is given in Figure 44.  
 
 
Figure 44. Schematic representation of one of the possible structural forms of 
[(NO3)2Cu-pAPTES]. 
 
The surface morphology of [(NO3)2Cu-pAPTES] obtained from the current study was 
imaged using SEM (Figure 45). The images show smooth blocks of polymer with some 
cracks on the surface. Pitting is visible on the lower magnification image (a) below, 
while the image take at higher magnification (b) has white flecks of copper visible on 
the surface.  
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(a) (b) 
Figure 45. SEM images of [(NO3)2Cu-pAPTES] under (a) low magnification and (b) high 
magnification. 
 
The SEM images obtained from the current study are similar to those reported by 
Owens129 (Figure 46), which have a block-like morphology with some cracks 
apparent. The image under high magnification (10 µm) reveals ridges. 
 
 
 
 
(a) (b) 
 
Figure 46. SEM images of p(APTES)Cu reported by Owens under (a) low magnification 
and (b) high magnification129. The sample was prepared using a 5:1 mole ratio of 
Cu(NO3)2:mAPTES. 
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The presence of copper(II) ions on the surface of the sample was confirmed by EDX 
(Figure 47). 
 
Figure 47. EDX spectrum of [(NO3)2Cu-pAPTES]. 
 
3.2.4 [(OAc)2Cu-pAPTES-Fe3O4-MNPs]      
 
Suspended black pAPTES-Fe3O4-MNPs (0.15 g) were reacted with an ethanolic 
solution of [Cu2(OAc)4(H2O)2] (0.05 g) to give black [(OAc)2Cu-pAPTES-Fe3O4-MNPs]. 
The apparent low mass yield (0.03 g) can principally be attributed to loss of solid 
during product recovery operations. The very finely dispersed powdery material did 
not settle fully throughout the numerous sedimentation/magnetic decantation 
process.  
 
As in the case of pAPTES-Fe3O4-MNPs (Figure 38), the IR spectrum of [(OAc)2Cu-
pAPTES-Fe3O4-MNPs] (Figure 48 (a)) is dominated by strong H-O-H and Fe-O bands 
(centred around 3422 and 600 cm-1, respectively). Very weak bands are present for 
the C-H and O-Si-O moieties (2923 and 1200-1000 cm-1, respectively). The acetate O-
C-O asymmetric vibration band is thought to be masked by the broad H-O-H/H-N-H 
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bending band centred around 1632 cm-1, whilst the weak, sharp band at 1385 cm-1 
could be due to the O-C-O symmetric stretch.  
Note that in the IR spectrum of [Cu2(OAc)4(H2O)2] (Figure 48 (b)), the prominent O-C-
O asym and O-C-O sym bands occur at 1602 and 1445 cm-1, respectively.  
 
(a) 
 
(b) 
Figure 48. IR spectra of (a) [(OAc)2Cu-pAPTES-Fe3O4-MNPs], and (b) 
[Cu2(OAc)4(H2O)2]. 
 
Microanalytical data for hydrated [(OAc)2Cu-pAPTES-Fe3O4-MNPs] (found: C 1.63%, H 
0.41%, N 0.29%: %C:%N ratio = 5.62:1) returned, an average, 1 CH2CH2CH2NH2 moiety 
for every 1 Cu(OAc)2 on the polymer-coated solid surface (this gives a theoretical 
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%C:%N ratio of 6.0:1). Again, if there is a tentative assumption of a homogeneous 
distribution of Cu(II) ions throughout the surface silicone coating, then the 
coordination environment around each Cu(II) centre could comprise two bidentate 
acetates and one propylamine, as illustrated in Figure 49.  
 
 
Figure 49. Schematic representation of one of the possible structural forms of 
[(OAc)2Cu-pAPTES-Fe3O4-MNPs]. 
 
SEM images of [(OAc)2Cu-pAPTES-Fe3O4-MNPs] (Figure 50) reveal a smooth surface, 
and one which was much more flaky than pAPTES (Figure 36). [(OAc)2Cu-pAPTES-
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Fe3O4-MNPs] was also devoid of the external rippling apparent on the Fe3O4-MNPs 
(Figure 29) and pAPTES-Fe3O4-MNPs (Figure 39) samples. 
 
  
(a) (b) 
Figure 50. SEM images of [(OAc)2Cu-pAPTES-Fe3O4-MNPs] under (a) low 
magnification and (b) high magnification. 
 
A qualitative EDX spectrum of [(OAc)2Cu-pAPTES-Fe3O4-MNPs] (Figure 51) confirmed 
the presence of surface iron, copper, silicon and oxygen. As expected, the copper 
content is very small in relation to the amount of surface iron.  
 
 
Figure 51. EDX spectrum of [(OAc)2Cu-pAPTES-Fe3O4-MNPs].   
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3.2.5 SalH-pAPTES 
 
Addition of salicylaldehyde (SalH) to neat mAPTES, (ca. 1:1 mole ratio) afforded the 
yellow solid, SalH-pAPTES. The strong C=O stretching band (1666 cm-1) that was 
present in the IR spectrum of SalH was absent from the spectrum of SalH-pAPTES 
(Figure 52). The latter material gave a prominent C=N band at 1634 cm-1, indicating 
formation of the Schiff base. The broad band spanning the region 1200-900 cm-1 
verified the creation of O-Si-O linkages in the polymer product.  
 
 
Figure 52. IR spectrum of SalH-pAPTES made using mAPTES. 
 
Addition of salicylaldehyde to preformed pAPTES also produced a yellow solid, the IR 
spectrum of which (Figure 53) was quite similar to that given by the SalH-pAPTES 
sample formed using mAPTES. Again, the absence of a C=O band implied that the 
polymer was free from unreacted aldehyde. 
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Figure 53. IR spectrum of SalH-pAPTES made using pAPTES. 
 
If it is assumed that all mAPTES has been converted into pAPTES in the SalH + mAPTES 
reaction, and that there are no encapsulated EtOH (liberated during the hydrolysis of 
silane monomer molecules) or EtOH molecules (from the product washing process), 
then microanalytical data for the product (found: C 31.79%, H 6.57%, N 9.80%; %C:%N 
= 3.24:1) suggests that ca. one in every nine pendant –CH2CH2CH2NH2 functions of 
the silicone polymer has undergone a Schiff base condensation reaction with 
salicylaldehyde to give a –CH2CH2CH2N=CH(C6H3–OH) moiety (gives a %C:%N ratio of 
3.24:1), as depicted in Figure 54. It is not known if there is a homogeneous distribution 
of the Schiff base residues throughout the product. 
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Figure 54. Schematic representation of the structure of SalH-pAPTES. 
 
Surprisingly, when Sing et al.137 refluxed a 1:1 mole mixture of SalH and mAPTES in 
MeOH only the Schiff base product formed with the monomer (SalH-mAPTES) and 
there was no mention of any Schiff base polymeric silicon material being produced 
at this stage (Scheme 3, Step(i)), even though they describe that the product of this 
reaction was a viscous, yellow material. This result appears somewhat strange given 
the fact that water, which is a stoichiometric by-product in a Schiff base condensation 
reaction, is known to promote the rapid hydrolysis of mAPTES and that this 
hydrolysed monomer, (OH)3SiCH2CH2CH2NH2, readily oligomerizes/polymerises. 
Furthermore, these authors also found that subsequent refluxing of their SalH-
mAPTES compound with copper(II) acetate gave the complex, [Cu-Sal-(mAPTES)2], in 
which the Cu(II) ion was coordinated by two deprotonated ligands (Scheme 3, 
Step(ii)). Silane polymerization only occurred when [Cu-Sal-(mAPTES)2] was refluxed 
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with the pre-calcined silica, Si-MCM 41, giving [Cu-Sal-(mAPTES)2-Si-MCM 41]  
(Scheme 3, Step(iii)). 
 
Scheme 3. Synthesis of the Cu(II)-Schiff base [Cu-Sal-(mAPTES)2-Si-MCM 41]137.  
 
SEM images of SalH-pAPTES made from SalH + mAPTES (Figure 55) and from SalH + 
pAPTES (Figure 56) indicate that surface morphology is dependent upon the synthetic 
protocol employed. The sample prepared using mAPTES has a rippled texture whilst 
that obtained using pAPTES has a somewhat flaky consistency. 
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(a) (b) 
Figure 55. SEM images of the SalH-pAPTES sample made from SalH + mAPTES under 
(a) low magnification and (b) high magnification. 
 
  
(a) (b) 
Figure 56. SEM images of the SalH-pAPTES sample made from SalH + pAPTES under 
(a) low magnification and (b) high magnification. 
 
3.2.6  SalH-pAPTES-Fe3O4-MNPs 
 
Addition of salicylaldehyde to an ethanolic suspension of pAPTES-Fe3O4-MNPs (ca. 1:2 
mass ratio) gives the brown powder, SalH-pAPTES-Fe3O4-MNPs. The IR spectrum of 
the material (Figure 57) is very similar to that of the precursor solid, pAPTES-Fe3O4-
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MNPs (Figure 38) and bands attributable to the salicylate moiety (e.g. aromatic C-H 
and C-C ring vibrations) are not clearly recognisable.  
 
Figure 57. IR spectrum of SalH-pAPTES-Fe3O4-MNPs.   
 
Microanalytical data for SalH-pAPTES-Fe3O4-MNPs (found: C 3.25%, H 0.47%, N 
0.08%) translates to a very large %C:%N ratio of 40.6:1. If all of the pendant 
propylamine functions on pAPTES-Fe3O4-MNPs had undergone a Schiff base 
condensation reaction then the theoretical %C:%N ratio should be 5.6:1. Given the 
extremely high %C:%N ratio found for SalH-pAPTES-Fe3O4-MNPs (40.6:1), the extra 
carbon content presumably comes from large quantities of EtOH (reaction and 
washing solvent used) tightly bound in the polymer matrix. Theoretical calculations 
show that, on average, for each pendant –CH2CH2CH2N=CH(C6H3–OH) moiety then 22 
EtOH molecules must be added to give a %C:%N ratio of 46.39:1. However, if solid 
SalH-pAPTES-Fe3O4-MNPs contained such a large quantity of EtOH then it would be 
anticipated that a reasonably pronounced aliphatic C-H stretching band (ca. 2900 cm-
1) would be visible in the IR spectrum of the sample. This was not the case. Figure 58 
shows only one of a number of structural possibilities for SalH-pAPTES-Fe3O4-MNPs 
(trapped EtOH molecules not included). 
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Figure 58. Schematic illustration of one of a number of structural possibilities for SalH-
pAPTES-Fe3O4-MNPs. 
 
At low magnification, SEM images of SalH-pAPTES-Fe3O4-MNPs (Figure 59) show an 
irregular, rough surface, which bore some resemblance to the surface of pAPTES-
Fe3O4-MNPs (Figure 39). At higher magnification, it became evident that the SalH-
pAPTES-Fe3O4-MNPs surface was constituted by a loose assembly of small particles of 
various shapes and sizes. 
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(a) (b) 
Figure 59. SEM images of SalH-pAPTES-Fe3O4-MNPs under (a) low magnification dn 
(b) high magnification. 
 
3.2.7 [Cu-Sal-pAPTES-Fe3O4-MNPs] 
 
Addition of [Cu2(OAc)4(H2O)2] to an ethanolic suspension of brown SalH-pAPTES-
Fe3O4-MNPs (0.05 g:0.12 g mass ratio) gave a relatively low mass yield (0.08 g) of [Cu-
Sal-pAPTES-Fe3O4-MNPs], which was also a brown powder. In addition to strong H-O-
H (3402 and 1567 cm-1), Si-O-Si (1300-1000 cm-1) and Fe-O (750-450 cm-1) bands, the 
IR spectrum of the product (Figure 60) also contained relatively weak aliphatic C-H 
and imine C=N stretching bands (2918 and 1626 cm-1, respectively). Likewise, Sing et 
al.137 reported C-H and C=N bands at essentially identical wavenumbers in the 
spectrum of their Cu(II) Schiff base polymer, [Cu-Sal-(mAPTES)2-Si-MCM 41] (see 
Scheme 3).  
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Figure 60. IR spectrum of [Cu-Sal-pAPTES-Fe3O4-MNPs].  
 
For [Cu-Sal-(mAPTES)2-Si-MCM 41], which was also derived using copper(II) acetate, 
Singh et al.137 indicated that charge balance for the encapsulated Cu2+ dications was 
provided by deprotonated phenolic oxygens from two salicylate residues, and not by 
acetate anions (Figure 53). Acetic acid will be the by-product formed upon 
combination of the released phenolic H+ ions with CH3CO2- ions. Metal coordination 
by the imine N and the phenolic O atoms gives stable, six-membered chelate rings. 
This is also thought to be the case with [Cu-Sal-pAPTES-Fe3O4-MNPs]. Support for this 
bonding comes from the fact that IR bands attributable to acetate O-C-O stretching 
were not evident in the spectra of [Cu-Sal-pAPTES-Fe3O4-MNPs] and [Cu-Sal-
(mAPTES)2-Si-MCM 41]137.  
 
Surprisingly, microanalytical data for [Cu-Sal-pAPTES-Fe3O4-MNPs] (found: C 1.22%, 
H 0.23%, N 0.17%) revealed a dramatic reduction in the %C:%N ratio (7.18:1) 
compared to the precursor material, SalH-pAPTES-Fe3O4-MNPs (40.6:1), where there 
are thought to be ca. 22 EtOH molecules trapped per pendant –
CH2CH2CH2N=CH(C6H3–OH) group. For [Cu-Sal-pAPTES-Fe3O4-MNPs], the established 
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7.18:1 %C:%N ratio is close to the theoretical value calculated (8.57:1) for a material 
in which the only carbon and nitrogen atoms present in the sample come from the –
CH2CH2CH2N=CH(C6H3–OH) moiety (i.e. the EtOH molecules trapped in SalH-pAPTES-
Fe3O4-MNPs are lost upon conversion to [Cu-Sal-pAPTES-Fe3O4-MNPs]). A structural 
schematic for one of a number of possible structures of [Cu-Sal-pAPTES-Fe3O4-MNPs] 
is given in Figure 61.  
 
 
 
Figure 61. Schematic diagram of one possible structure for [Cu-Sal-pAPTES-Fe3O4-
MNPs].  
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SEM images of [Cu-Sal-pAPTES-Fe3O4-MNPs] (Figure 62) show particles which have a 
relatively smooth outer top layer and a rougher edge topography. At the higher 
magnification (50 μm scale), the surface texture appears to be smoother than its 
precursor material, SalH-pAPTES-Fe3O4-MNPs (Figure 57), which is undoubtedly 
attributable to the presence of chelated Cu(II) ions and the absence of trapped EtOH 
molecules in the material. 
(a) (b) 
Figure 62. SEM images of [Cu-Sal-pAPTES-Fe3O4-MNPs].   
   
A qualitative EDX spectrum of [Cu-Sal-pAPTES-Fe3O4-MNPs] (Figure 63) confirmed the 
presence of surface iron, copper, silicon and oxygen. As expected, the Cu(II) content 
appeared to be quite small.  
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Figure 63. EDX spectrum of [Cu-Sal-pAPTES-Fe3O4-MNPs]. 
 
3.3 pTMSPDT Materials 
 
3.3.1 pTMSPDT 
 
As outlined in the established literature procedures138,139, hydrolysis and subsequent 
condensation of mTMSPDT occurs in aqueous media at room temperature to give the 
colourless pTMSPDT solid in good mass yield. Although microanalytical data (found: 
C 39.04%, H 8.16%, N 18.06%; %C:%N = 2.16:1) correlated well with that reported by 
Owens129 (found: C 39.42%, H 8.33%, N 17.73%; %C:%N = 2.22:1) the elemental 
composition values were significantly less than those predicted by the theoretical 
calculations for pure pTMSPDT of formulation (C7H18N3SiO3/2)n (calc.: C 42.83%, H 
9.24%, N 21.40%; %C:%N = 2.00:1). This was the same scenario as that witnessed in 
the case of pAPTES. The larger %C:%N ratio found for the synthesised pTMSPDT 
sample (2.22:1) infers incorporation of methanol in the solid (can arise from 
hydrolysis of methoxy groups on the monomer and/or the reaction/washing solvent). 
Theoretical calculations show that for each pendant -(CH2)3NH(CH2)2NH(CH2)2NH2 
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moiety there is, on average, ca. 1 MeOH molecule present (gives a %C:%N ratio of 
2.29:1). 
 
The IR spectrum of pTMSPDT (Figure 64) was very similar to that of pAPTES (Figure 
33) and contained bands associated with trapped water and the various structural 
moieties constituting the polymer matrix (to avoid unnecessary repetition, band 
frequencies are not discussed here but these are outlined in the Experimental 
Section).  
 
Figure 64. IR spectrum of pTMSPDT. 
 
The somewhat weak 1H NMR (D2O solvent) spectrum of sparingly soluble pTMSPDT 
(Figure 65) was very similar to that given by Owens129. The spectrum showed peaks 
centred at δ 2.77 (m, Hc-g), 1.62 (m, Hb) and 0.54 (t, Ha). 
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Figure 65. 1H NMR (D2O) spectrum of pTMSPDT.  
 
A schematic representing the structure of pTMSPDT is given in Figure 66. 
 
Figure 66. A schematic representing the structure of pTMSPDT (incorporated MeOH 
not shown). 
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The smooth surface topography of pTMSPDT (Figure 67) was very similar to that of 
pAPTES (Figure 36). 
 
Figure 67. SEM images of pTMSPDT.      
 
3.3.2 pTMSPDT-Fe3O4-MNPs 
 
Black pTMSPDT-Fe3O4-MNPs were synthesised using a modified published method49, 
in which an aqueous methanolic suspension of Fe3O4-MNPs were treated with 
mTMSPDT in a ca. 2.8:1 mole ratio at room temperature. As was found in the case of 
the IR spectrum of pAPTES-Fe3O4-MNPs (Figure 38), the spectrum of pTMSPDT-Fe3O4-
MNPs (Figure 68) is dominated by very strong Fe-O bands (800-450 cm-1) and 
moderately intense H-O-H and Si-O-Si bands (3401 and 1300-1100 cm-1, respectively). 
A strong aliphatic C-H band was evident at 2933 cm-1. 
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Figure 68. IR spectrum of pTMSPDT-Fe3O4-MNPs.   
 
Microanalytical data (found: C 2.76%; H 0.68%, N 0.75%; %C:%N = 3.68:1) shows a 
significantly higher carbon content than that calculated for the 
propyldiethylenetriamine moiety, -(CH2)3NH(CH2)2NH(CH2)2NH2  (calculated %C:%N = 
2:1), again implying incorporation of methanol in the solid. It has been calculated that 
there are an average of 6 MeOH molecules present for each pendant 
_(CH2)3NH(CH2)2NH(CH2)2NH2 moiety (gives a %C:%N ratio of 3.17:1). 
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A schematic representation of the structure of pTMSPDT-Fe3O4-MNPs is shown in 
Figure 69.  
 
 
Figure 69. A schematic representation of the structure of pTMSPDT-Fe3O4-MNPs 
(incorporated MeOH molecules not shown). 
 
The high magnification SEM image of pTMSPDT-Fe3O4-MNPs (Figure 70; 10 μm) 
reveals a flaky, layered morphology, and one which is quite different to the 
smooth/granular surfaces in pAPTES-Fe3O4-MNPs (Figure 39). 
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(a) (b) 
Figure 70. SEM images of pTMSPDT-Fe3O4-MNPs. 
 
3.3.3 [(NO3)2Cu-pTMSPDT] 
 
Glass-like flakes of [(NO3)2Cu-pTMSPDT] could be made by reacting Cu(NO3)2.3H2O 
with either monomeric mTMSPDT or polymeric pTMSPDT in water. However, the 
mass yield in both reactions was quite small. Although the bulk appearance and royal 
blue colour of [(NO3)2Cu-pTMSPDT] was very similar to that of [(NO3)2Cu-pAPTES], the 
mass yield of the latter material was much superior. As expected, the IR spectra of 
[(NO3)2Cu-pAPTES] (Figure 43) and [(NO3)2Cu-pTMSPDT] (Figure 71) were quite alike, 
with both showing a strong, sharp nitrate band at 1384 cm-1 and also prominent H-O-
H/amine and Si-O-Si bands (3600-3000 and 1200-850 cm-1, respectively, for 
[(NO3)2Cu-pTMSPDT]). The IR spectra of [(NO3)2Cu-pTMSPDT] samples made using 
either mTMSPDT or pTMSPDT were identical. 
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Figure 71. IR spectrum of [(NO3)2Cu-pTMSPDT].   
 
Although microanalytical data found for [(NO3)2Cu-pTMSPDT] samples made using 
either mTMSPDT or pTMSPDT solids were different, the %C:%N ratios were quite 
similar (found using mTMSPDT: C 19.43%, H 4.69%, N 16.55%; %C:%N = 1.18:1: found 
using pTMSPDT: C 16.98%, H 4.03%, N 13.28%; %C:%N = 1.29:1). Theoretical 
calculations     show     that     a    ratio     of     one     Cu(NO3)2      per   one   pendant     
-(CH2)3NH(CH2)2NH(CH2)2NH2 moiety renders a %C:%N = 1.20:1, suggesting that each 
triamine functionality in the [(NO3)2Cu-pTMSPDT] solid is coordinated to a Cu(II) 
centre giving two 5-membered chelate rings. A metal coordination number of four or 
five (as is usual for Cu2+ ions140) can be accomplished by the binding of water 
molecules. A schematic representation of one of a number of possible structural 
motifs for [(NO3)2Cu-pTMSPDT] is shown in Figure 72. 
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Figure 72. A schematic representation of one of the possible structural motifs for 
[(NO3)2Cu-pTMSPDT]. 
 
The surface topography of [(NO3)2Cu-pTMSPDT] made using mTMSPDT (Figure 73) 
showed smooth surfaces with some small bumps and ridges visible. The images of 
[(NO3)2Cu-pTMSPDT] made using pTMSPDT (Figure 74) showed globular formations 
on the surface under low magnification, which were very similar to those of 
[(NO3)2Cu-pTMSPDT] made using mTMSPDT (Figure 73). 
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(a) (b) 
 
(c) 
Figure 73. SEM images of [(NO3)2Cu-pTMSPDT] made using mTMSPDT. 
 
Qualitative EDX spectra of [(NO3)2Cu-pTMSPDT] made using mTMSPDT (Figure 75 (a)) 
and pTMSPDT (Figure 75 (b)) confirmed the presence of carbon, copper, silicon and 
oxygen in both samples. 
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(a) 
 
(b) 
 
(c) 
Figure 74. [(NO3)2Cu-pTMSPDT] made using pTMSPDT. 
 
  
(a) (b) 
Figure 75. EDX spectra of [(NO3)2Cu-pTMSPDT] made using (a) mTMSPDT and (b) 
pTMSPDT. 
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3.3.4 [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] 
 
Addition of [Cu2(OAc)4(H2O)2] to a dispersion of pTMSPDT-Fe3O4-MNPs in methanol 
gave a moderate mass yield of black [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs]. The IR 
spectrum of the product (Figure 76) was almost identical to that of [(OAc)2Cu-pAPTES-
Fe3O4-MNPs] (Figure 48), with the strongest intensity bands being associated with H-
O-H/ H-N-H/N-H stretches and Fe-O stretches (centred around 3420 and 580 cm-1, 
respectively). The O-C-O asymmetric band is hidden under the broad H-O-H/H-N-H 
bending band (centred ca. 1632 cm-1) whilst the weak, sharp band at 1385 cm-1 is 
believed to be the O-C-O symmetric stretching vibration. Very weak bands are 
present for the acetate C-H and silicone O-Si-O moieties (2918 and 1200-1000 cm-1, 
respectively).  
 
Figure 76. IR spectrum of [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs].   
 
Microanalytical results for [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] (found: C 10.42%, H 
0.49%, N 0.43%; %C:%N = 24.23:1) indicated a very large %C:%N ratio, implying quite 
a high relative proportion of carbon in the material. A number of different 
formulations were tried in an attempt to match theoretical with found %C:%N figures. 
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If encapsulated solvent MeOH molecules are not factored into the formulation of 
[(OAc)2Cu-pTMSPDT-Fe3O4-MNPs], then for each 1 pendant {-
(CH2)3NH(CH2)2NH(CH2)2NH2} moiety there would be a requirement of 20 Cu(OAc)2  
units to give gave a theoretical %C:%N value of 24.93:1, which is very close to the 
found value (24.23:1). This is in stark contrast to that found for [(OAc)2Cu-pAPTES-
Fe3O4-MNPs], where it was estimated that 1 Cu(OAc)2 was associated with 1 pendant 
-(CH2)3NH2 moiety. If solvent MeOH molecules are factored into the formulation of 
[(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] then a number of different (-
(CH2)3NH(CH2)2NH(CH2)2NH2 + Cu(OAc)2 + MeOH) theoretical combinations could be 
used to match the found %C:%N ratio. For example, the combination of 1 -
(CH2)3NH(CH2)2NH(CH2)2NH2 + 12 Cu(OAc)2 + 30 MeOH gives a theoretical %C:%N of 
24.28:1, whilst 1 -(CH2)3NH(CH2)2NH(CH2)2NH2 + 15 Cu(OAc)2 + 20 MeOH gives a 
theoretical %C:%N of 24.86:1. Given that the product was not rigorously dried under 
vacuum, then it is a logical assumption that MeOH molecules are resident in the solid. 
Each -(CH2)3NH(CH2)2NH(CH2)2NH2 functionality in [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] 
is expected to coordinate to the Cu(II) centre to give two 5-membered chelate rings. 
In addition, there is the possibility for either one or both of the acetate anions to bind 
to the metal through the carboxylate oxygens (a large variety of carboxylate 
coordination modes are possible141). A schematic representation of one of a large 
number of possible structures for [(OAc)2Cu-pAPTES-Fe3O4-MNPs] is shown in Figure 
77. 
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Figure 77. Schematic representation of one possible structure of [(OAc)2Cu-
pTMSPDT-Fe3O4-MNPs] (additional Cu(OAc)2 and solvent MeOH molecules not 
shown). 
 
SEM images of [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] (Figure 78) reveal a smooth, flaky 
surface, and one which closely resemble that of its pAPTES analogue, [(OAc)2Cu-
pAPTES-Fe3O4-MNPs] (Figure 50). The EDX spectrum of [(OAc)2Cu-pTMSPDT-Fe3O4-
MNPs] (Figure 79) is also very similar to that of [(OAc)2Cu-pAPTES-Fe3O4-MNPs] 
(Figure 51) and endorses the presence of a large quantity of surface iron and oxygen 
along with much smaller amounts of copper and silicon.  
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Figure 78. SEM images of [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs]. 
 
 
Figure 79. EDX spectrum of [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs]. 
 
3.3.5 SalH-pTMSPDT 
 
By emulating a previously published procedure129, yellow SalH-pTMSPDT was 
prepared in good yield by reacting salicylaldehyde with mTMSPDT (1:1 mole ratio) in 
water. The IR spectrum of the product (Figure 80) was very similar to that of yellow 
SalH-pAPTES (Figure 52), which was formed by the interaction of salicylaldehyde with 
pAPTES. Again, the prominent C=N band at 1634 cm-1 was verification of Schiff base 
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formation, whilst the broad O-Si-O band (1200-900 cm-1) confirmed the creation of 
the silicone polymer. 
 
 
Figure 80. IR spectrum of SalH-pTMSPDT.  
 
Microanalytical data for SalH-pTMSPDT (found: C 55.99%, H 6.82%, N 12.72%; %C:%N 
= 4.4:1) implies that each pendant -(CH2)3NH(CH2)2NH(CH2)2NH2 moiety has reacted 
with a salicylaldehyde to form the corresponding  Schiff base entity, -
(CH2)3NH(CH2)2NH(CH2)2N=CH(C6H3–OH). Inclusion of 1 MeOH molecule (formed 
during the hydrolysis of monomeric mTMSPDT molecules) along with each -
(CH2)3NH(CH2)2NH(CH2)2N=CH(C6H3–OH) entity gives a theoretical %C:%N ratio 
(4.29:1) which is close to that found for the sample. The fact that every pendant -
(CH2)3NH(CH2)2NH(CH2)2NH2 moiety in mTMSPDT gets converted to a Schiff base is in 
stark contrast to that found for mAPTES, where only one in every nine  pendant –
CH2CH2CH2NH2 functions forms the Schiff base entity. 
 
A schematic representing the structure of SalH-pTMSPDT is given in Figure 81. 
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Figure 81. Schematic representation of the structure of SalH-pTMSPDT (encapsulated 
MeOH molecules not shown). 
 
SEM images of SalH-pTMSPDT made using mTMSPDT reveal very smooth surfaces 
with some ridges visible (Figure 82). 
  
Figure 82. SEM images of SalH-pTMSPDT. 
     
~ 108 ~ 
 
3.3.6 SalH-pTMSPDT-Fe3O4-MNPs 
 
Addition of a methanolic solution of salicylaldehyde to pTMSPDT-Fe3O4-MNPs gave 
SalH-pTMSPDT-Fe3O4-MNPs as a brown powder. As anticipated, the IR spectrum of 
the product (Figure 83) closely resembled that of the pAPTES analogue, SalH-pAPTES-
Fe3O4-MNPs (Figure 57), with the principal bands arising from the H-O-H/H-N-H/N-H 
and Fe-O vibrations (3434 and 790-450 cm-1, respectively). Much weaker bands were 
evident for the aliphatic C-H and Si-O-Si stretches (2929 and 1350-1070 cm-1, 
respectively) of the SalH-pAPTES moiety. 
 
Figure 83. IR spectrum of SalH-pTMSPDT-Fe3O4-MNPs.  
 
Microanalytical data for SalH-pTMSPDT-Fe3O4-MNPs (found: C 8.65%, H 0.53%, N 
0.51%; %C:%N = 16.96:1) show that the solid contains a substantial quantity of extra 
carbon atoms. If it is accepted that all of the pendant -(CH2)3NH(CH2)2NH(CH2)2NH2 
functions on pTMSPDT-Fe3O4-MNPs have undergone a Schiff base condensation 
reaction, as was evidenced in the formation of SalH-pTMSPDT, then the theoretical 
%C:%N ratio should be 4:1. It is thought that the extra carbon content comes from 
encapsulated EtOH molecules (this assumes that the copious quantities of EtOH used 
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in the washing protocol has displaced any entrapped MeOH which was employed as 
the reaction solvent). Theoretical calculations show that, on average, for each 
pendant -(CH2)3NH(CH2)2NH(CH2)2N=CH(C6H3–OH) moiety then 23 EtOH molecules 
must be added to give a %C:%N ratio of 17.1:1. This is a similar situation to that found 
in the case of SalH-pAPTES-Fe3O4-MNPs. 
 
A schematic representation of the structure of SalH-pTMSPDT-Fe3O4-MNPs is shown 
in Figure 84. 
 
Figure 84. Schematic representation of the structure of SalH-pTMSPDT-Fe3O4-MNPs 
(trapped EtOH molecules not shown). 
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SEM images reveal that SalH-pTMSPDT-Fe3O4-MNPs (Figure 85) has a much smoother 
surface profile than the somewhat granular pAPTES analogue, SalH-pAPTES-Fe3O4-
MNPs (Figure 59). The smooth surface of SalH-pTMSPDT-Fe3O4-MNPs was similar to 
that of SalH-pTMSPDT (Figure 82).  
 
  
Figure 85. SEM images of SalH-pTMSPDT-Fe3O4-MNPs.  
 
3.3.7 [Cu-Sal-pTMSPDT-Fe3O4-MNPs] 
 
Treating a methanolic dispersion of SalH-pTMSPDT-Fe3O4-MNPs with 
[Cu2(OAc)4(H2O)2] (2:1 mass ratio) affords the black powder, [Cu-Sal-pTMSPDT-Fe3O4-
MNPs]. Not surprisingly, the IR spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs] (Figure 
86) is almost identical to that of its precursor material, SalH-pTMSPDT-Fe3O4-MNPs 
(Figure 83). Although there are many similarities between the IR spectra of [Cu-Sal-
pTMSPDT-Fe3O4-MNPs] and its pAPTES relative, [Cu-Sal-pAPTES-Fe3O4-MNPs] (Figure 
60), the spectrum of the latter material has much more pronounced Si-O-Si bands.  
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As mentioned earlier (Section 3.2.7), in the cases of [Cu-Sal-(mAPTES)2-Si-MCM 41]137 
and [Cu-Sal-pAPTES-Fe3O4-MNPs], which were both synthesised using copper(II) 
acetate, charge balance for the encapsulated Cu2+ dications is provided by 
deprotonated phenolic oxygens from two salicylate residues, and not by acetate 
anions. This is also believed to be the case with [Cu-Sal-pTMSPDT-Fe3O4-MNPs], with 
the metal being chelated by the imine N and the phenolic O atoms as well as by amine 
N atoms. As with [Cu-Sal-pAPTES-Fe3O4-MNPs], acetate O-C-O bands were not 
apparent in the IR spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs].   
 
Figure 86. IR spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs].    
 
Microanalytical data showed that for [Cu-Sal-pTMSPDT-Fe3O4-MNPs] (found: C 
5.32%, H 0.52%, N 0.51%; %C:%N = 10.43:1) an average of 22 MeOH molecules must 
be added for each pendant -(CH2)3NH(CH2)2NH(CH2)2N=CH(C6H3–OH) moiety 
(theoretical %C:%N ratio = 10.29:1). 
 
A schematic illustrating one of a number of possible structures of [Cu-Sal-pTMSPDT-
Fe3O4-MNPs] is given in Figure 87.  
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Figure 87. Schematic for one of a number of possible structures of [Cu-Sal-pTMSPDT-
Fe3O4-MNPs] (MeOH molecules not shown). Note that two deprotonated phenolic 
oxygens from two salicylate residues are required for charge balance. 
 
SEM images of [Cu-Sal-pTMSPDT-Fe3O4-MNPs] (Figure 88) show a relatively smooth 
underlying surface which is dashed with numerous small, coarse-textured eruptions. 
The latter features are absent in images of both the precursor material, SalH-
pTMSPDT-Fe3O4-MNPs (Figure 85) and the pAPTES analogue, [Cu-Sal-pAPTES-Fe3O4-
MNPs] (Figure 63). The EDX spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs] (Figure 89) 
is similar to that exhibited by [Cu-Sal-pAPTES-Fe3O4-MNPs] (Figure 63) and shows the 
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presence of copious quantities of surface iron, silicon and oxygen and a tiny amount 
of copper.    
 
 
(a) (b) 
Figure 88. SEM images of [Cu-Sal-pTMSPDT-Fe3O4-MNPs] under (a) low magnification 
and (b) high magnification. 
 
The EDX spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs] (Figure 89) confirms the 
presence of carbon, oxygen, iron and copper. 
   
Figure 89. EDX spectrum of [Cu-Sal-pTMSPDT-Fe3O4-MNPs].  
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3.4 Anti-Candida Activity 
 
The qualitative results of in vitro tests to determine the activity of the materials 
against the growth of the fungal pathogen, C. albicans, are given in Table 3. After 
seeding petri dishes with Candida cells, three samples of the same solid test material 
were added and the dishes incubated at 37 °C for 20 h. After this period, the dishes 
were visually inspected for signs of growth inhibition. Images of the actual culture 
dishes containing the test materials and the C. albicans cells are given in Figures 91-
93. 
 
As expected, uncoated Fe3O4-MNPs did not deter fungal cells reproduction (Figure 90 
(a)). Indeed, it is possible that Fe3O4-MNPs may even have provided a convenient 
source of iron ions which are known to be essential for sustaining healthy cell 
growth142. The silicone polymers, pAPTES and pTMSPDT (Figures 90 (b) and 92 (a), 
respectively), both deterred the growth of C. albicans as was evidenced by the clear 
zones of inhibition around the sample areas. It is thought that the pendant amine 
moieties present in both of these amino-functionalised silicone polymers could be 
effectively sequestering transition metal ions from critical metalloenzymes present in 
the fungal cell which causes enzyme malfunction and the ultimate demise of the 
organism. A similar hypothesis has been used to account for the devastating effects 
on C. albicans induced by the metal-free chelating ligands, 1,10-phenanthroline96 99 
and 1,10-phenanthroline-5,6-dione143.     
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Table 3. Results from visual inspection of petri dishes containing C. albicans and 
administered solid test materials.  
 
 
Materials 
 
Inhibition of growth of C. albicans 
Fe3O4-MNPs no inhibition 
pAPTES Inhibition 
pAPTES-Fe3O4-MNPs no inhibition 
[(NO3)2Cu-pAPTES]  Inhibition 
[(OAc)2Cu-pAPTES-Fe3O4-MNPs] no inhibition 
SalH-pAPTES Inhibition 
SalH-pAPTES-Fe3O4-MNPs no inhibition 
[Cu-Sal-pAPTES-Fe3O4-MNPs] no inhibition 
pTMSPDT Inhibition 
pTMSPDT-Fe3O4-MNPs no inhibition 
[(NO3)2Cu-pTMSPDT]  Inhibition 
[(NO3)2Cu-pTMSPDT]  Inhibition 
[(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] no inhibition 
SalH-pTMSPDT Inhibition 
SalH-pTMSPDT-Fe3O4-MNPs no inhibition 
[Cu-Sal-pTMSPDT-Fe3O4-MNPs] no inhibition 
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(a) Fe3O4-MNPs 
  
(b) pAPTES 
 
 
 
 
(c) pAPTES-Fe3O4-MNPs (d) [(NO3)2Cu-pAPTES] 
 
Figure 90. Petri dishes with growing C. albicans cells and administered test material. 
(a) Fe3O4-MNPs (no inhibition); (b) pAPTES (inhibition); (c) pAPTES-Fe3O4-MNPs (no 
inhibition); (d) [(NO3)2Cu-pAPTES] (inhibition). 
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(a) [(OAc)2Cu-pAPTES-Fe3O4-MNPs (b) SalH-pAPTES 
  
 
 
(c) SalH-pAPTES-Fe3O4-MNPs (d) [Cu-Sal-pAPTES-Fe3O4-MNPs] 
 
Figure 91. Petri dishes with growing C. albicans cells and administered test material. 
(a) [(OAc)2Cu-pAPTES-Fe3O4-MNPs] (no inhibition); (b) Sal-pAPTES (inhibition); (c) 
SalH-pAPTES-Fe3O4-MNPs (no inhibition); (d) [Cu-Sal-pAPTES-Fe3O4-MNPs] (no 
inhibition). 
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(a) pTMSPDT (b) pTMSPDT-Fe3O4-MNPs 
 
  
(c) [(NO3)2Cu-pTMSPDT] (d) [(NO3)2Cu-pTMSPDT] 
 
Figure 92. Petri dishes with growing C. albicans cells and administered test material. 
(a) pTMSPDT (inhibition); (b) pTMSPDT-Fe3O4-MNPs (no inhibition); (c) [(NO3)2Cu-
pTMSPDT] (inhibition); (d) [(NO3)2Cu-pTMSPDT] (inhibition). 
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(a) [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] 
 
(b) SalH-pTMSPDT 
  
(c) SalH-pTMSPDT-Fe3O4-MNPs (d) [Cu-Sal-pTMSPDT-Fe3O4-MNPs] 
 
Figure 93. Petri dishes with growing C. albicans cells and administered test material. 
(a) [(OAc)2Cu-pTMSPDT-Fe3O4-MNPs] (no inhibition); (b) SalH-pTMSPDT (inhibition); 
(c) SalH-pTMSPDT-Fe3O4-MNPs (no inhibition); (d) [Cu-Sal-pTMSPDT-Fe3O4-MNPs] 
(no inhibition). 
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The Schiff base salicylates, SalH-pAPTES and SalH-pTMSPDT (Figures 94 (b) and 96 (b), 
respectively), also promoted cell death and again this is being attributed to their 
ability to requisition metals from vital cellular enzymes.       
 
The Cu(II)-containing silicone polymers which were not surface bonded to Fe3O4-
MNPs i.e. [(NO3)2Cu-pAPTES] and [(NO3)2Cu-pTMSPDT] (Figures 93 (d) and 95 (c) and 
(d), respectively), were also lethal to the fungal cells. A combination of released toxic 
Cu(II) ions and deactivation of metalloezymes by the now free pendant amine 
functionalities is thought to be responsible for the fate of the cell. 
 
In contrast to the good activity demonstrated by the silicone polymers, their salicylate 
Schiff base derivatives and their Cu(II) complexes, all of these materials were inactive 
when coated onto the surface of Fe3O4-MNPs. It is believed that there are insufficient 
quantities of the silicones (with or without Cu(II) ions) present on the surface of the 
nanoparticles to enable an antimicrobial effect.  
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Conclusion 
 
The replication of literature procedures for the polymerisation of monomeric (3-
aminopropyl)triethoxysilane (APTES) and (3-trimethoxysilylpropyl)diethylene 
triamine (TMSPDT) affords the colourless, amine-functionalised silicone polymers 
(pAPTES and pTMSPDT) in good yield. Subsequent condensation reactions of the 
silicones with salicylaldehyde gives the corresponding yellow, Schiff base derivatives. 
In the case of pAPTES, only 10% of the pendant 3-aminopropyl groups condense with 
the aldehyde, whilst all of the terminal amine groups of pTMSPDT transformed to 
imines. Increasing the concentration of added salicylaldehyde and/or prolonging the 
reaction time might enhance the extent of Schiff base conversion for pAPTES. 
 
Magnetic nanoparticles (Fe3O4-MNPs) are readily procured using a standardised 
synthetic protocol involving a specific molar combination of simple Fe(II) and Fe(III) 
salts. Surface coating of the Fe3O4-MNPs with pAPTES and pTMSPDT is achieved by 
interaction of the nanoparticles with the appropriate aminosilane monomer. Again, 
the Schiff base adducts are obtained upon reaction with salicylaldehyde. Whereas 
the naked, highly aggregated Fe3O4-MNPs can readily be recovered from suspension  
using a strong permanent magnet, the silicone-coated Fe3O4-MNPs are much less 
aggregated and require high-speed centrifugation for product recovery (which is 
usually incomplete and results in low mass yields). 
 
Coordination of Cu(II) ions to the pendant amine functionalities of the silicone 
materials occurs upon treatment with simple copper(II) salts. 
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A combination of microanalytical and IR spectral data are used to characterize the 
solid polymers which, with the exception of pAPTES and pTMSPDT are insoluble. 
Most of the materials retain large quantities of trapped water or alcohol, even after 
vacuum desiccation at ca. 50 °C. Given that the polymeric products are likely to be 
inhomogeneous it is not possible to offer ‘exact’ chemical structures for the 
materials, and only ‘possible’ structural entities can be inferred.  Unsurprisingly, a 
wide variation in surface morphologies is seen across the various polymers with some 
consistencies being observed between pAPTES and pTMSPDT analogues. 
 
Only pAPTES, pTMSPDT, their Cu(II) complexes and the Schiff base derivatives of the 
aminosilanes deter the growth of the fungal pathogen, Candida albicans. 
Disappointingly, none of the coated Fe3O4-MNPs were active. It is thought that there 
are only minimal amounts of bioactive amine groups and Cu(II) ions present on the 
nanoparticle surfaces, presumed to arise from the relatively large particle sizes 
(which translates to a small surface area). Decreasing particle size (with consequent 
increases in surface area), through possible modification of the Fe3O4-MNPs 
synthesis protocol, may enhance the antimicrobial performance. Coordination of 
alternative transition metals with known high antifungal activity (e.g. Ag(I), Mn(II)) 
could also improve the bioactivity. 
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